CancerPPD 2.0 - Year of Publication

Browsing Year-wise

Browse Results:

Filter by Length
Minimum Length
Maximum Length

ID	PMID	YEAR	Sequence	Name	Length	Linear/Cyclic	Chirality	Chem-MOD	C-ter MOD	N-ter MOD	Nature	Origin	Cell Line	Cancer Type	Assay	Activity	Testing Time	Tissue Affected	Patents
5272	None	2015	CHYRVKPKIKRFEKYKGRMW	LPSBD-2	20	Linear	L	None	Free	Free	Anticancer	Synthetic	Hep3B	Liver Cancer	Cell Proliferation assay	~40% cell survival at 60 µg/ml	24-h	Liver	None
5271	None	2015	CHYRVKPKIKRFEKYKGRMW	LPSBD-2	20	Linear	L	None	Free	Free	Anticancer	Synthetic	A-549	Lung Cancer	Cell Proliferation assay	~20% cell survival at 60 µg/ml	24-h	Lung	None
5270	None	2015	CQYSVNPKIKRFELYFKGRMW	LPSBD-0	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Hep3B	Liver Cancer	Cell Proliferation assay	~40% cell survival at 60 µg/ml	24-h	Liver	None
5268	25854366	2015	FIGAIARLL	BmKn-24	9	Linear	L	None	Free	Free	Antimicrobial	Derivative of Bmkn-2	HSC-4	Tongue Squamous Cell Carcinoma	MTT assay	IC₅₀ between 29-97 µg/ml	24-h	Tongue	None
5269	None	2015	CQYSVNPKIKRFELYFKGRMW	LPSBD-0	21	Linear	L	None	Free	Free	Anticancer	Synthetic	A-549	Lung Cancer	Cell Proliferation assay	~20% cell survival at 60 µg/ml	24-h	Lung	None
5266	25854366	2015	FIGAIARLLSKI	Bmkn-21	12	Linear	L	None	Free	Free	Antimicrobial	Derivative of Bmkn-2	HSC-4	Tongue Squamous Cell Carcinoma	MTT assay	IC₅₀ between 29-97 µg/ml	24-h	Tongue	None
5267	25854366	2015	FIGAIARLLS	BmKn-23	10	Linear	L	None	Free	Free	Antimicrobial	Derivative of Bmkn-2	HSC-4	Tongue Squamous Cell Carcinoma	MTT assay	IC₅₀ between 29-97 µg/ml	24-h	Tongue	None
5264	25854366	2015	FIGAIARLLSKIF	BmKn2	13	Linear	L	None	Free	Free	Antimicrobial	Mesobuthus martensii Karsch	HSC-4	Tongue Squamous Cell Carcinoma	MTT assay	IC₅₀ = 29 µg/mL	24-h	Tongue	None
5265	25854366	2015	FIGAIARLLSK	Bmkn-22	11	Linear	L	None	Free	Free	Antimicrobial	Derivative of Bmkn-2	HSC-4	Tongue Squamous Cell Carcinoma	MTT assay	IC₅₀ between 29-97 µg/ml	24-h	Tongue	None
5263	25802281	2015	AQQICKAPSQTFPGLCFMDSSCRKYCIKEKFTGGHCSKLQRKCLCTKPC	TPP3	49	Linear	L	None	Free	Free	Antifungal	pistils from tomato flowers	U-937	Leukemia Cancer	LDH leakage assay	35% cytotoxicity at 10 μM	Not Available	Blood	None
5258	26527862	2015	RRRQRRKKRGGGGlgaswhrpdkcclgyqkrrlpGGGLRRMADDLNAQY	TAT-DV1-BH3	49	Linear	Mix	None	Free	Free	Anticancer	Synthetic polypeptide	MDA-MB-231	Breast cancer	CCK-8 assay	Survival rate = 28.67±8.22% at 80 µM	72-h	Breast	None
5259	26527862	2015	RRRQRRKKRGGGGlgaswhrpdkcclgyqkrrlpGGGLRRMADDLNAQY	TAT-DV1-BH3	49	Linear	Mix	None	Free	Free	Anticancer	Synthetic polypeptide	MCF-7	Breast cancer	CCK-8 assay	Survival rate = 36.97±4.22% at 80 µM	72-h	Breast	None
5262	25802281	2015	AQQICKAPSQTFPGLCFMDSSCRKYCIKEKFTGGHCSKLQRKCLCTKPC	TPP3	49	Linear	L	None	Free	Free	Antifungal	pistils from tomato flowers	U-937	Leukemia Cancer	PI uptake assay	69.6% cell death at 10 μM	Not Available	Blood	None
5257	25462264	2015	VKRFKKFFRKLKKEV	B1-Glu	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 36.6 µM	24-h	Blood	None
5256	25462264	2015	VKRFKKFFRKLKKEV	B1-Glu	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 38.9 µM	24-h	Breast	None
5254	25462264	2015	VKRFKKFFRKLKKDV	B1-Asp	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 19.9 µM	24-h	Breast	None
5255	25462264	2015	VKRFKKFFRKLKKDV	B1-Asp	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 44.7 µM	24-h	Blood	None
5253	25462264	2015	VKRFKKFFRKLKKHV	B1-His	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 10.5 µM	24-h	Blood	None
5252	25462264	2015	VKRFKKFFRKLKKHV	B1-His	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 5.0µM	24-h	Breast	None
5250	25462264	2015	VKRFKKFFRKLKKRV	B1-Arg	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 5.5 µM	24-h	Breast	None
5251	25462264	2015	VKRFKKFFRKLKKRV	B1-Arg	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 8.7 µM	24-h	Blood	None
5249	25462264	2015	VKRFKKFFRKLKKKV	B1-Lys	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562/ADM	Leukemia cancer	MTT assay	IC₅₀ = 5.5 µM	24-h	Blood	None
5247	25462264	2015	VKRFKKFFRKLKKKV	B1-Lys	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 5.5 µM	24-h	Blood	None
5248	25462264	2015	VKRFKKFFRKLKKKV	B1-Lys	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 8.6 µM	24-h	Breast	None
5246	25462264	2015	VKRFKKFFRKLKKKV	B1-Lys	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 8.3 µM	24-h	Breast	None
5245	25462264	2015	VKRFKKFFRKLKKTV	B1-Thr	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 17.0 µM	24-h	Blood	None
5243	25462264	2015	VKRFKKFFRKLKKQV	B1-Gln	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 16.2 µM	24-h	Blood	None
5244	25462264	2015	VKRFKKFFRKLKKTV	B1-Thr	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 19.1 µM	24-h	Breast	None
5242	25462264	2015	VKRFKKFFRKLKKQV	B1-Gln	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 14.5 µM	24-h	Breast	None
5241	25462264	2015	VKRFKKFFRKLKKGV	B1-Gly	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 14.8 µM	24-h	Blood	None
5239	25462264	2015	VKRFKKFFRKLKKFV	B1-Phe	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 3.7 µM	24-h	Blood	None
5240	25462264	2015	VKRFKKFFRKLKKGV	B1-Gly	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 15.8 µM	24-h	Breast	None
5238	25462264	2015	VKRFKKFFRKLKKFV	B1-Phe	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 1.3 µM	24-h	Breast	None
5237	25462264	2015	VKRFKKFFRKLKKLV	B1-Leu	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562/ADM	Leukemia cancer	MTT assay	IC₅₀ = 3.3 µM	24-h	Blood	None
5236	25462264	2015	VKRFKKFFRKLKKLV	B1-Leu	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 4.4 µM	24-h	Breast	None
5235	25462264	2015	VKRFKKFFRKLKKLV	B1-Leu	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 1.1 µM	24-h	Blood	None
5233	25462264	2015	VKRFKKFFRKLKKVV	B1-Val	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 5.0 µM	24-h	Blood	None
5234	25462264	2015	VKRFKKFFRKLKKLV	B1-Leu	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 3.6 µM	24-h	Breast	None
5232	25462264	2015	VKRFKKFFRKLKKVV	B1-Val	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 4.9 µM	24-h	Breast	None
5231	25462264	2015	VKRFKKFFRKLKKAV	B1-Ala14	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	K-562	Leukemia cancer	MTT assay	IC₅₀ = 8.6 µM	24-h	Blood	None
5230	25462264	2015	VKRFKKFFRKLKKAV	B1-Ala14	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of B1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 8.9 µM	24-h	Breast	None
5228	25462264	2015	VKRFKKFFRKLKKSV	B1	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Cathelicidin-BF15	MCF-7/ADM	Breast Cancer	MTT assay	IC₅₀ = 24.1 µM	24-h	Breast	None
5229	25462264	2015	VKRFKKFFRKLKKSV	B1	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Cathelicidin-BF15	K-562/ADM	Leukemia cancer	MTT assay	IC₅₀ = 31.6 µM	24-h	Blood	None
5227	25462264	2015	VKRFKKFFRKLKKSV	B1	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Cathelicidin-BF15	K-562	Leukemia cancer	MTT assay	IC₅₀ = 26.9 µM	24-h	Blood	None
5224	27486068	2015	PcatPhexPhexPcat	Lipotetrapeptide-C16-PCatPCatPCatPCat-NH2	4	Linear	L	Pcat = L-4R-aminoproline ; Phex = L-4R-hexyloxyproline	Amidation	Palmitic acid	Anticancer	Synthetic	DU-145	Prostate Cancer	MTS assay	CC₅₀ = 16.5 µM	73-76h	Prostate	None
5225	27486068	2015	PcatPhexPhexPcat	Lipotetrapeptide-C16-PCatPCatPCatPCat-NH2	4	Linear	L	Pcat = L-4R-aminoproline ; Phex = L-4R-hexyloxyproline	Amidation	Palmitic acid	Anticancer	Synthetic	MiaPaCa.2	Pancreatic Cancer	MTS assay	CC₅₀ = 23 µM	73-76h	Pancreas	None
5226	25462264	2015	VKRFKKFFRKLKKSV	B1	15	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Cathelicidin-BF15	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 21.9 µM	24-h	Breast	None
5221	27486068	2015	KKKK	C16-Lipotetrapeptide	4	Linear	L	None	Amidation	Palmitic acid	Anticancer	Synthetic	DU-145	Prostate Cancer	MTS assay	CC₅₀ = 18 µM	73-76h	Prostate	None
5222	27486068	2015	PcatPhexPhexPcat	Lipotetrapeptide-C16-PCatPCatPCatPCat-NH2	4	Linear	L	Pcat = L-4R-aminoproline ; Phex = L-4R-hexyloxyproline	Amidation	Palmitic acid	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	MTS assay	CC₅₀ = 12.5 µM	73-76h	Breast	None
5223	27486068	2015	PcatPhexPhexPcat	Lipotetrapeptide-C16-PCatPCatPCatPCat-NH2	4	Linear	L	Pcat = L-4R-aminoproline ; Phex = L-4R-hexyloxyproline	Amidation	Palmitic acid	Anticancer	Synthetic	JIMT-1	Breast Cancer	MTS assay	CC₅₀ = 17 µM	73-76h	Breast	None
5218	27486068	2015	KKK	C16-Liptotripeptide	3	Linear	L	None	Amidation	Palmitic acid	Anticancer	Synthetic	MiaPaCa.2	Pancreatic Cancer	MTS assay	CC₅₀ =16 µM	73-76h	Pancreas	None
5219	27486068	2015	KKKK	C16-Lipotetrapeptide	4	Linear	L	None	Amidation	Palmitic acid	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	MTS assay	CC₅₀ = 30 µM	73-76h	Breast	None
5220	27486068	2015	KKKK	C16-Lipotetrapeptide	4	Linear	L	None	Amidation	Palmitic acid	Anticancer	Synthetic	JIMT-1	Breast Cancer	MTS assay	CC₅₀ = 30 µM	73-76h	Breast	None
5215	27486068	2015	KKK	C14-Liptotripeptide	3	Linear	L	None	Amidation	Myristic acid	Anticancer	Synthetic	DU-145	Prostate Cancer	MTS assay	CC₅₀ =10 µM	73-76h	Prostate	None
5216	27486068	2015	KKK	C16-Liptotripeptide	3	Linear	L	None	Amidation	Palmitic acid	Anticancer	Synthetic	JIMT-1	Breast Cancer	MTS assay	CC₅₀ = 10 µM	73-76h	Breast	None
5217	27486068	2015	KKK	C16-Liptotripeptide	3	Linear	L	None	Amidation	Palmitic acid	Anticancer	Synthetic	DU-145	Prostate Cancer	MTS assay	CC₅₀ = 9 µM	73-76h	Prostate	None
5214	25447543	2015	ACYCRIPACIAGERRYGTCIYQGRLWAFCC	Human neutrophil peptide-1 (HNP-1)	30	Cyclic(C2-C30, C4-C19,C9-C29)	L	None	Free	Free	Antimicrobial	Homo sapiens	PC-3	Prostate Cancer	Cytotoxicity assay (LIVE/DEAD® Viability/Cytotoxicity Assay Kit (L-3224))	IC₅₀ = 2.2 ± 0.3 μM	4h	Prostate	None
5212	25633717	2015	Str given in figure	KEMTUB10	4	Linear	L	None	fluorine atom in para-position on the phenyl ring	N-tubuvaline fragment replaced with stable benzyl group	Anti-cancer	Synthetic analogue of natural tubulysins	MDA-MB-453	Breast Cancer	MTT assay	IC₅₀ = 16.3 ± 5.6 pM	72-h	Breast	None
5213	25633717	2015	Str given in figure	KEMTUB10	4	Linear	L	None	fluorine atom in para-position on the phenyl ring	N-tubuvaline fragment replaced with stable benzyl group	Anti-cancer	Synthetic analogue of natural tubulysins	SK-BR-3	Breast Cancer	MTT assay	IC₅₀ = 12.2 ± 6 pM	72-h	Breast	None
5210	25633717	2015	Str given in figure	KEMTUB10	4	Linear	L	None	fluorine atom in para-position on the phenyl ring	N-tubuvaline fragment replaced with stable benzyl group	Anti-cancer	Synthetic analogue of natural tubulysins	MCF-7/DD	Breast Cancer	MTT assay	IC₅₀ = 68.6 ± 30.1 pM	72-h	Breast	None
5211	25633717	2015	Str given in figure	KEMTUB10	4	Linear	L	None	fluorine atom in para-position on the phenyl ring	N-tubuvaline fragment replaced with stable benzyl group	Anti-cancer	Synthetic analogue of natural tubulysins	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 68 ± 18 pM	72-h	Breast	None
5209	25633717	2015	Str given in figure	KEMTUB10	4	Linear	L	None	fluorine atom in para-position on the phenyl ring	N-tubuvaline fragment replaced with stable benzyl group	Anti-cancer	Synthetic analogue of natural tubulysins	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 30.1 ± 13.2 pM	72-h	Breast	US 8,580,820; US (US 2011/200581).
5204	26482932	2015	LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN	Cytotoxin-II	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	HL-60	Leukemia Cancer	LDH leakage assay	IC₅₀ = 23.01 μg/mL	24-h	Blood	None
5203	26482932	2015	LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN	Cytotoxin-II	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	DU-145	Prostrate Cancer	LDH leakage assay	IC₅₀ = 15.91 μg/mL	24-h	Prostate	None
5202	26482932	2015	LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN	Cytotoxin-II	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	HepG-2	Liver Cancer	LDH leakage assay	IC₅₀ = 28.99 μg/mL	24-h	Liver	None
5201	26482932	2015	LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN	Cytotoxin-II	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	MCF-7	Breast Cancer	LDH leakage assay	IC₅₀ = 23.9 μg/mL	24-h	Breast	None
5200	26482932	2015	LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN	Cytotoxin-II	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	HL-60	Leukemia Cancer	MTT assay	IC₅₀ < 20 μg/mL	24-h	Blood	None
5199	26482932	2015	LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN	Cytotoxin-II	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	DU-145	Prostrate Cancer	MTT assay	IC₅₀ ~ 15 μg/mL	24-h	Prostate	None
5198	26482932	2015	LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN	Cytotoxin-II	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	HepG-2	Liver Cancer	MTT assay	IC₅₀ ~ 20 μg/mL	24-h	Liver	None
5197	26482932	2015	LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN	Cytotoxin-II	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	MCF-7	Breast Cancer	MTT assay	IC₅₀ ~ 10 μg/mL	24-h	Breast	None
5192	26482932	2015	LKCNKLVPIAYKTCPEGKNLCYKMFMMSDLTIPVKRGCIDVCPKNSLLVKYVCCNTDRCN	Cytotoxin-I	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	HL-60	Leukemia Cancer	LDH leakage assay	IC₅₀ = 38.3 μg/mL	24-h	Blood	None
5191	26482932	2015	LKCNKLVPIAYKTCPEGKNLCYKMFMMSDLTIPVKRGCIDVCPKNSLLVKYVCCNTDRCN	Cytotoxin-I	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	DU-145	Prostrate Cancer	LDH leakage assay	IC₅₀ = 20.99 μg/mL	24-h	Prostate	None
5190	26482932	2015	LKCNKLVPIAYKTCPEGKNLCYKMFMMSDLTIPVKRGCIDVCPKNSLLVKYVCCNTDRCN	Cytotoxin-I	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	HepG-2	Liver Cancer	LDH leakage assay	IC₅₀ = 35.84 μg/mL	24-h	Liver	None
5189	26482932	2015	LKCNKLVPIAYKTCPEGKNLCYKMFMMSDLTIPVKRGCIDVCPKNSLLVKYVCCNTDRCN	Cytotoxin-I	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	MCF-7	Breast Cancer	LDH leakage assay	IC₅₀ = 45.71 μg/mL	24-h	Breast	None
5188	26482932	2015	LKCNKLVPIAYKTCPEGKNLCYKMFMMSDLTIPVKRGCIDVCPKNSLLVKYVCCNTDRCN	Cytotoxin-I	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	HL-60	Leukemia Cancer	MTT assay	IC₅₀ < 40 μg/mL	24-h	Blood	None
5187	26482932	2015	LKCNKLVPIAYKTCPEGKNLCYKMFMMSDLTIPVKRGCIDVCPKNSLLVKYVCCNTDRCN	Cytotoxin-I	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	DU-145	Prostrate Cancer	MTT assay	IC₅₀ ~ 20 μg/mL	24-h	Prostate	None
5186	26482932	2015	LKCNKLVPIAYKTCPEGKNLCYKMFMMSDLTIPVKRGCIDVCPKNSLLVKYVCCNTDRCN	Cytotoxin-I	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	HepG-2	Liver Cancer	MTT assay	IC₅₀ ~ 40 μg/mL	24-h	Liver	None
5185	26482932	2015	LKCNKLVPIAYKTCPEGKNLCYKMFMMSDLTIPVKRGCIDVCPKNSLLVKYVCCNTDRCN	Cytotoxin-I	60	Cyclic	L	None	Free	Free	Anticancer	Caspian cobra (Naja oxiana) venom	MCF-7	Breast Cancer	MTT assay	IC₅₀ < 20 μg/mL	24-h	Breast	None
5183	25821084	2015	CVLIGQRCDNDRGPRCCSGQGNCVPLPFLGGVCAV	Ep-AMP1	35	Cyclic	L	None	Cyclized	Cyclized	Antibacterial and Anticancer	Echinopsis pachanoi	U-937/GTB	Lymphoma cancer	Fluorometric microculture cytotoxicity assay	IC₅₀ > 100 µM	Not Available	Blood	None
5182	26322745	2015	GLPTCGETCFKGKCYTPGCSCSYPICKKD	Cyclotide mela-6	29	Cyclic	L	None	Cyclized	Cyclized	Antibacterial and Anticancer	Melicytus latifolius	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 11.42 ±1.00 µM	Not Available	Cervix	None
5181	26322745	2015	GLPTCGETCFKGKCYTPGCSCSYPICKKD	Cyclotide mela-6	29	Cyclic	L	None	Cyclized	Cyclized	Antibacterial and Anticancer	Melicytus latifolius	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.58 ±0.48 µM	Not Available	Skin	None
5180	26399495	2015	GIPCGESCVFIPCLTSAIGCSCKSKVCYRN	Mra30	30	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial and Anticancer	Viola tricolor, Melicytus ramiflorus, Viola philippica	BGC-823	Gastric Cancer	Resazurin dye assay	IC₅₀ = 1.75 ±0.05 µM	Not Available	Stomach	None
5179	26399495	2015	GIPCGESCVFIPCLTSAIGCSCKSKVCYRN	Mra30	30	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial and Anticancer	Viola tricolor, Melicytus ramiflorus, Viola philippica	HeLa	Cervical Cancer	Resazurin dye assay	IC₅₀ = 15.5 ±0.06 µM	Not Available	Cervix	None
5178	26399495	2015	GIPCGESCVFIPCLTSAIGCSCKSKVCYRN	Mra30	30	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial and Anticancer	Viola tricolor, Melicytus ramiflorus, Viola philippica	MM96L	Skin Cancer	Resazurin dye assay	IC₅₀ = 4.91 ±0.04 µM	Not Available	Skin	None
5177	26322745	2015	GKPICGETCFKGKCYTPGCTCSYPICKKD	Mela3	29	Cyclic	L	None	Cyclized	Cyclized	Antibacterial and Anticancer	Melicytus latifolius	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 18.73 ±1.82 µM	Not Available	Cervix	None
5175	25974307	2015	NYNQPNS	IturinA	7	Cyclic	L	None	Cyclized; C16 Fatty acid moiety	Cyclized	Lipopeptide	Bacillus megaterium	MDA-MB-468	Breast Cancer	MTT assay	IC₅₀ = 13.30 ± 0.97 μM	48-h	Breast	None
5176	26322745	2015	GKPICGETCFKGKCYTPGCTCSYPICKKD	Mela3	29	Cyclic	L	None	Cyclized	Cyclized	Antibacterial and Anticancer	Melicytus latifolius	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.04 ±0.26 µM	Not Available	Skin	None
5172	25974307	2015	NYNQPNS	IturinA	7	Cyclic	L	None	Cyclized; C16 Fatty acid moiety	Cyclized	Lipopeptide	Bacillus megaterium	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 7.98 ± 0.19 μM	48-h	Breast	None
5173	25974307	2015	NYNQPNS	IturinA	7	Cyclic	L	None	Cyclized; C16 Fatty acid moiety	Cyclized	Lipopeptide	Bacillus megaterium	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 12.16 ± 0.24 μM	48-h	Breast	None
5174	25974307	2015	NYNQPNS	IturinA	7	Cyclic	L	None	Cyclized; C16 Fatty acid moiety	Cyclized	Lipopeptide	Bacillus megaterium	T-47D	Breast Cancer	MTT assay	IC₅₀ = 26.29 ± 0.78 μM	48-h	Breast	None
5169	26703631	2015	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin	33	Linear	L	None	Free	Free	Antimicrobial	Pardachirus marmoratus	OSCC-SCC-4	Oral cancer	MTT assay	Cell Viability <20% at 20μg/mL	24-h	Not Available	None
5167	25626077	2015	FLFKLIPKVIKGLVKAIRK	AaeAP2a	19	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic analog of AaeAP2	MCF-7	Breast Cancer	MTT assay	Graph Figure 4	24-h	Breast	None
5168	25626077	2015	FLFKLIPKVIKGLVKAIRK	AaeAP2a	19	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic analog of AaeAP2	PC-3	Prostate Cancer	MTT assay	Graph Figure 4	24-h	Prostate	None
5166	25626077	2015	FLFKLIPKVIKGLVKAIRK	AaeAP2a	19	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic analog of AaeAP2	MDA-MB-435S	Skin Cancer	MTT assay	Graph Figure 4	24-h	Skin	None
5164	25626077	2015	FLFKLIPKAIKGLVKAIRK	AaeAP1a	19	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic analog of AaeAP1	MCF-7	Breast Cancer	MTT assay	Graph Figure 4	24-h	Breast	None
5165	25626077	2015	FLFKLIPKAIKGLVKAIRK	AaeAP1a	19	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic analog of AaeAP1	PC-3	Prostate Cancer	MTT assay	Graph Figure 4	24-h	Prostate	None
5163	25626077	2015	FLFKLIPKAIKGLVKAIRK	AaeAP1a	19	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic analog of AaeAP1	MDA-MB-435S	Skin Cancer	MTT assay	Graph Figure 4	24-h	Skin	None
5162	26751970	2015	GLPLCGETCVGGTCNTPGCSCGWPVCVRN	Vigno 5	29	Cyclic(C5-C19,C9-C21,C14-C21)	L	None	Free	Free	Anticancer	Viola ignobilis	HeLa	Cervical Cancer	MTT assay	24% cell viability at 7.5 μM	24-h	Cervix	None
5158	26064310	2015	GAFLKCGESCVYLPCLTTVVGCSCQNSVCYRD	DC1	32	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Hedyotis diffusa	DU-145	Liver Cancer	CCK-8 assay	IC₅₀ = 3.32 μM	72-h	Liver	None
5157	26064310	2015	GAFLKCGESCVYLPCLTTVVGCSCQNSVCYRD	DC1	32	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Hedyotis diffusa	PC-3	Prostate Cancer	CCK-8 assay	IC₅₀ = 2.24 μM	72-h	Prostate	None
5156	26064310	2015	GAFLKCGESCVYLPCLTTVVGCSCQNSVCYRD	DC1	32	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Hedyotis diffusa	LNCaP	Prostate Cancer	CCK-8 assay	IC₅₀ = 5.03 μM	72-h	Prostate	None
5155	26064310	2015	GAVPCGETCVYLPCITPDIGCSCQNKVCYRD	DC2	31	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Hedyotis diffusa	DU-145	Liver Cancer	CCK-8 assay	IC₅₀ = 3.11 μM	72-h	Liver	None
5154	26064310	2015	GAVPCGETCVYLPCITPDIGCSCQNKVCYRD	DC2	31	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Hedyotis diffusa	PC-3	Prostate Cancer	CCK-8 assay	IC₅₀ = 2.65 μM	72-h	Prostate	None
5153	26064310	2015	GAVPCGETCVYLPCITPDIGCSCQNKVCYRD	DC2	31	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Hedyotis diffusa	LNCaP	Prostate Cancer	CCK-8 assay	IC₅₀ = 4.31 μM	72-h	Prostate	None
5152	26064310	2015	GTSCGETCVLLPCLSSVLGCTCQNKRCYKD	DC3	30	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Hedyotis diffusa	DU-145	Liver Cancer	CCK-8 assay	IC₅₀ = 0.55 μM	72-h	Liver	None
5151	26064310	2015	GTSCGETCVLLPCLSSVLGCTCQNKRCYKD	DC3	30	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Hedyotis diffusa	PC-3	Prostate Cancer	CCK-8 assay	IC₅₀ = 0.76 μM	72-h	Prostate	None
5150	26064310	2015	GTSCGETCVLLPCLSSVLGCTCQNKRCYKD	DC3	30	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Hedyotis diffusa	LNCaP	Prostate Cancer	CCK-8 assay	IC₅₀ = 0.21 μM	72-h	Prostate	None
5149	26402731	2015	GFGSKPLDSFGLNFF	Chaxapeptin	15	Mix	L	None	Free	Cyclized to form macrolactam ring	Antimicrobial and Anticancer	Streptomyces leeuwenhoekii Strain C58	A-549	Lung Cancer	CyQUANT Direct assay	Cell invasion < 50% at 50 μM	36-h	Lung	None
5148	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-668	Gastric cancer	LDH release assay	Cytotoxicity ~ 60-80% at 50 μM	24-h	Stomach	None
5147	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-638	Gastric cancer	LDH release assay	Cytotoxicity ~ 60-80% at 50 μM	24-h	Stomach	None
5146	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-601	Gastric cancer	LDH release assay	Cytotoxicity ~ 60-80% at 50 μM	24-h	Stomach	None
5145	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-484	Gastric cancer	LDH release assay	Cytotoxicity ~ 60-80% at 50 μM	24-h	Stomach	None
5144	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-668	Gastric cancer	MTS assay	IC₅₀ ~ 20-50 μM	24-h	Stomach	None
5143	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-638	Gastric cancer	MTS assay	IC₅₀ ~ 20-50 μM	24-h	Stomach	None
5142	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-601	Gastric cancer	MTS assay	IC₅₀ ~ 20-50 μM	24-h	Stomach	None
5141	25047444	2015	LLCIALRKKLLCIALRKK	CopA3	18	Linear	L	None	Amidation	Free	Antimicrobial	analogue derived from coprisin	SNU-484	Gastric cancer	MTS assay	IC₅₀ ~ 20-50 μM	24-h	Stomach	None
5139	26405806	2015	FKKLKKLFSKLWNWKRKKRRQRRR	HPRP-A1-TAT	24	Linear	L	None	Amidation	Acetylation	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 1.8 ± 0.02 μM	24-h	Cervix	None
5138	26405806	2015	FKKLKKLFSKLWNWKRKKRRQRRR	HPRP-A1-TAT	24	Linear	L	None	Amidation	Acetylation	Anticancer	Synthetic	B-16	Skin Cancer	MTT assay	IC₅₀ = 3.9 ± 0.02 μM	24-h	Skin	None
5137	26405806	2015	FKKLKKLFSKLWNWKRKKRRQRRR	HPRP-A1-TAT	24	Linear	L	None	Amidation	Acetylation	Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 5.8 ± 0.36 μM	24-h	Liver	None
5136	26405806	2015	FKKLKKLFSKLWNWKRKKRRQRRR	HPRP-A1-TAT	24	Linear	L	None	Amidation	Acetylation	Anticancer	Synthetic	SGC-7901	Gastric cancer	MTT assay	IC₅₀ = 4.8 ± 0.08 μM	24-h	Stomach	None
5135	26405806	2015	FKKLKKLFSKLWNWK	HPRP-A1	15	Linear	L	None	Amidation	Acetylation	Anticancer	Helicobacter pylori	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 3.5 ± 0.03 μM	24-h	Cervix	None
5134	26405806	2015	FKKLKKLFSKLWNWK	HPRP-A1	15	Linear	L	None	Amidation	Acetylation	Anticancer	Helicobacter pylori	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 7.7 ± 0.23 μM	24-h	Liver	None
5133	26405806	2015	FKKLKKLFSKLWNWK	HPRP-A1	15	Linear	L	None	Amidation	Acetylation	Anticancer	Helicobacter pylori	SGC-7901	Gastric cancer	MTT assay	IC₅₀ = 5.2 ± 0.14 μM	24-h	Stomach	None
5132	26405806	2015	FKKLKKLFSKLWNWK	HPRP-A1	15	Linear	L	None	Amidation	Acetylation	Anticancer	Helicobacter pylori	B-16	Skin Cancer	MTT assay	IC₅₀ = 6.1 ± 0.02 μM	24-h	Skin	None
5131	26239537	2015	WWRRWWRRWRRWWRRWWR	RW-AH	18	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ = 4.6 ± 0.2 μM	24-h	Skin	None
5130	26239537	2015	WWRRWWRRWRRWWRRWWR	RW-AH	18	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 8.4 ± 0.5 μM	24-h	Skin	None
5129	26239537	2015	WWRRWWRRWRRWWRRWWR	RW-AH	18	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	PI uptake assay	LC₅₀ = 4.5 ± 0.02 μM	8-h	Skin	None
5128	26239537	2015	FWQRRIRRWRRFWQRRIRRWRR	DIM-LF11-318	22	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ = 9.4 ± 0.5 μM	24-h	Skin	None
5127	26239537	2015	FWQRRIRRWRRFWQRRIRRWRR	DIM-LF11-318	22	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 9.3 ± 0.8 μM	24-h	Skin	None
5126	26239537	2015	FWQRRIRRWRRFWQRRIRRWRR	DIM-LF11-318	22	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	PI uptake assay	LC₅₀ = 3.8 ± 0.5 μM	8-h	Skin	None
5125	26239537	2015	PFWRRRIRIRRRRIRIRRRWFP	R-DIM-LF11-337	22	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ = 5.0 ± 0.4 μM	24-h	Skin	None
5124	26239537	2015	PFWRRRIRIRRRRIRIRRRWFP	R-DIM-LF11-337	22	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 12.3 ± 1.3 μM	24-h	Skin	None
5123	26239537	2015	PFWRRRIRIRRRRIRIRRRWFP	R-DIM-LF11-337	22	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	PI uptake assay	LC₅₀ = 3.5 ± 0.4 μM	8-h	Skin	None
5122	26239537	2015	PFWRIRIRRPRRIRIRWFP	R-DIM-P-LF11-322	19	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ = 10.4 ± 0.7 μM	24-h	Skin	EP_2943215_B1
5121	26239537	2015	PFWRIRIRRPRRIRIRWFP	R-DIM-P-LF11-322	19	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 23.3 ± 1.7 μM	24-h	Skin	EP_2943215_B1
5120	26239537	2015	PFWRIRIRRPRRIRIRWFP	R-DIM-P-LF11-322	19	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	SBcl2	Skin Cancer	PI uptake assay	LC₅₀ = 5.9 ± 0.3 μM	8-h	Skin	EP_2943215_B1
5119	26239537	2015	PFWRIRIRRPRRIRIRWFP	R-DIM-P-LF11-322	19	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	PI uptake assay	LC₅₀ = 9.5 ± 0.3 μM	8-h	Skin	EP_2943215_B1
5115	25970292	2015	KKKKKK-Nal-Nal-KKWRKWLAKK	K6-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	SAS	Oral Cancer	MTT assay	Graph Figure 2	24-h	Tongue	None
5114	25970292	2015	KKKKKK-Nal-Nal-KKWRKWLAKK	K6-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	OECM-1	Oral Cancer	MTT assay	Graph Figure 2	24-h	Not Available	None
5113	25970292	2015	KKKKKK-Nal-Nal-KKWRKWLAKK	K6-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	C9	Oral Cancer	MTT assay	Graph Figure 2	24-h	Not Available	None
5112	25970292	2015	KKKKKK-Nal-Nal-KKWRKWLAKK	K6-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
5111	25970292	2015	KKKKKK-Nal-Nal-KKWRKWLAKK	K6-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	PC-9G	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
5110	25970292	2015	KKKKKK-Nal-Nal-KKWRKWLAKK	K6-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	PC-9	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
5109	25970292	2015	KKKKRR-Nal-Nal-KKWRKWLAKK	K4R2-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	SAS	Oral Cancer	MTT assay	Graph Figure 2	24-h	Tongue	None
5108	25970292	2015	KKKKRR-Nal-Nal-KKWRKWLAKK	K4R2-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	OECM-1	Oral Cancer	MTT assay	Graph Figure 2	24-h	Not Available	None
5107	25970292	2015	KKKKRR-Nal-Nal-KKWRKWLAKK	K4R2-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	C9	Oral Cancer	MTT assay	Graph Figure 2	24-h	Not Available	None
5106	25970292	2015	KKKKRR-Nal-Nal-KKWRKWLAKK	K4R2-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
5105	25970292	2015	KKKKRR-Nal-Nal-KKWRKWLAKK	K4R2-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	PC-9G	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
5104	25970292	2015	KKKKRR-Nal-Nal-KKWRKWLAKK	K4R2-Nal2-S1	18	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	PC-9	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	None
5103	25970292	2015	Nal-Nal-KKWRKWLAKK	Nal2-S1	12	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	SAS	Oral Cancer	MTT assay	Graph Figure 2	24-h	Tongue	US_10093699_B2
5102	25970292	2015	Nal-Nal-KKWRKWLAKK	Nal2-S1	12	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	OECM-1	Oral Cancer	MTT assay	Graph Figure 2	24-h	Not Available	US_10093699_B2
5101	25970292	2015	Nal-Nal-KKWRKWLAKK	Nal2-S1	12	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	C9	Oral Cancer	MTT assay	Graph Figure 2	24-h	Not Available	US_10093699_B2
5100	25970292	2015	Nal-Nal-KKWRKWLAKK	Nal2-S1	12	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	US_10093699_B2
5099	25970292	2015	Nal-Nal-KKWRKWLAKK	Nal2-S1	12	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	PC-9G	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	US_10093699_B2
5098	25970292	2015	Nal-Nal-KKWRKWLAKK	Nal2-S1	12	Linear	L	Nal = beta-naphthylalanine	Amidation	Acetylation	Antimicrobial	Synthetic	PC-9	Lung Cancer	MTT assay	Graph Figure 2	24-h	Lung	US_10093699_B2
5093	25312253	2014	GGRSFFLLRRIQGCRFRNTVDD	E5	22	Linear	L	None	Free	Free	Anticancer	Synthetic	U-937	Leukemia Cancer	FITC-Annexin V/PI double staining and flow cytometry assay	>20% apoptosis rate at 80 μM	24-h	Blood	None
5092	25312253	2014	GGRSFFLLRRIQGCRFRNTVDD	E5	22	Linear	L	None	Free	Free	Anticancer	Synthetic	HL-60	Leukemia Cancer	FITC-Annexin V/PI double staining and flow cytometry assay	>20% apoptosis rate at 80 μM	24-h	Blood	None
5091	25312253	2014	GGRSFFLLRRIQGCRFRNTVDD	E5	22	Linear	L	None	Free	Free	Anticancer	Synthetic	NB-4	Leukemia Cancer	FITC-Annexin V/PI double staining and flow cytometry assay	60% apoptosis rate at 80 μM	24-h	Blood	None
5090	24692446	2014	RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC	NaD1	47	Cyclic(C3-C47,C14-34,C20-C41,C24-C43)	L	None	None	None	Host Defense	Nicotiana alata	B16-F10	Skin Cancer	MTT assay	IC₅₀ = 1.5 ± 0.6 μM	48-h	Skin	None
5089	24692446	2014	RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC	NaD1	47	Cyclic(C3-C47,C14-34,C20-C41,C24-C43)	L	None	None	None	Host Defense	Nicotiana alata	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 1.0 ± 0.1 μM	48-h	Cervix	None
5088	24692446	2014	RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC	NaD1	47	Cyclic(C3-C47,C14-34,C20-C41,C24-C43)	L	None	None	None	Host Defense	Nicotiana alata	MM170	Skin Cancer	MTT assay	IC₅₀ = 2.4 ± 0.8 μM	48-h	Skin	None
5087	24692446	2014	RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC	NaD1	47	Cyclic(C3-C47,C14-34,C20-C41,C24-C43)	L	None	None	None	Host Defense	Nicotiana alata	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 2.0 ± 1.3 μM	48-h	Breast	None
5086	24692446	2014	RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC	NaD1	47	Cyclic(C3-C47,C14-34,C20-C41,C24-C43)	L	None	None	None	Host Defense	Nicotiana alata	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 4.9 ± 3.1 μM	48-h	Colon	None
5085	24503375	2014	RLGDGCTR	Cyclosaplin	8	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Santalum album L	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 2.06 μg/mL	24-h	Breast	638/KOL/2013
5084	24692199	2014	Wa(D-allo-i)VlL	Baceridin	6	Cyclic	Mix	None	Cyclized	Cyclized	Antimicrobial and Anticancer	culture medium of a plant-associated Bacillus strain	HeLa	Cervical Cancer	MTT assay	IC₅₀ between (1–2 µg/mL)	72-h	Cervix	None
5083	24692199	2014	Wa(D-allo-i)VlL	Baceridin	6	Cyclic	Mix	None	Cyclized	Cyclized	Antimicrobial and Anticancer	culture medium of a plant-associated Bacillus strain	RKO	Colon Cancer	MTT assay	IC₅₀ between (1–2 µg/mL)	72-h	Colon	None
5082	24692199	2014	Wa(D-allo-i)VlL	Baceridin	6	Cyclic	Mix	None	Cyclized	Cyclized	Antimicrobial and Anticancer	culture medium of a plant-associated Bacillus strain	HCT-116 -/- p53	Colon Cancer	MTT assay	IC₅₀ between (1–2 µg/mL)	72-h	Colon	None
5081	24704757	2014	GLVGTLLGHIGKAILG	Frenatin 2.1S	16	Linear	L	None	alpha-amidation	Free	Antimicrobial	Sphaenorhynchus lacteus	A-549	Lung Cancer	Trypan blue assay	LC₅₀ = 80 ± 6 μM	24-h	Lung	None
5080	24704757	2014	GLVGTLLGHIGKAILS	Frenatin 2.2S	16	Linear	L	None	alpha-amidation	Free	Antimicrobial	Sphaenorhynchus lacteus	A-549	Lung Cancer	Trypan blue assay	LC₅₀ = 75 ± 5 μM	24-h	Lung	None
5079	24492520	2014	ELLVDLL	Gageostatin C	7	Linear	L	None	Free	(E)-7,9-dimethylundec-2-enoic acid	Antimicrobial	Bacillus subtilis	ACHN	Renal Cancer	Sulforhodamine B assay	GI₅₀ = 12.3 µg/mL	48-h	Kidney	None
5077	24492520	2014	ELLVDLL	Gageostatin C	7	Linear	L	None	Free	(E)-7,9-dimethylundec-2-enoic acid	Antimicrobial	Bacillus subtilis	NCI-H23	Lung Cancer	Sulforhodamine B assay	GI₅₀ = 10.9 µg/mL	48-h	Lung	None
5078	24492520	2014	ELLVDLL	Gageostatin C	7	Linear	L	None	Free	(E)-7,9-dimethylundec-2-enoic acid	Antimicrobial	Bacillus subtilis	NUGC-3	Stomach Cancer	Sulforhodamine B assay	GI₅₀ = 10.5 µg/mL	48-h	Stomach	None
5075	24492520	2014	ELLVDLL	Gageostatin C	7	Linear	L	None	Free	(E)-7,9-dimethylundec-2-enoic acid	Antimicrobial	Bacillus subtilis	HCT-15	Colon Cancer	Sulforhodamine B assay	GI₅₀ = 23.2 µg/mL	48-h	Colon	None
5076	24492520	2014	ELLVDLL	Gageostatin C	7	Linear	L	None	Free	(E)-7,9-dimethylundec-2-enoic acid	Antimicrobial	Bacillus subtilis	PC-3	Prostate Cancer	Sulforhodamine B assay	GI₅₀ = 11.7 µg/mL	48-h	Prostate	None
5073	24492520	2014	ELLVDLL	Gageostatin B	7	Linear	L	None	Free	3-beta-hydroxy-9,11-dimethyltridecanoic acid	Antimicrobial	Bacillus subtilis	ACHN	Renal Cancer	Sulforhodamine B assay	GI₅₀ = 18.4 µg/mL	48-h	Kidney	None
5074	24492520	2014	ELLVDLL	Gageostatin C	7	Linear	L	None	Free	(E)-7,9-dimethylundec-2-enoic acid	Antimicrobial	Bacillus subtilis	MDA-MB-231	Breast Cancer	Sulforhodamine B assay	GI₅₀ = 11.2 µg/mL	48-h	Breast	None
5072	24492520	2014	ELLVDLL	Gageostatin B	7	Linear	L	None	Free	3-beta-hydroxy-9,11-dimethyltridecanoic acid	Antimicrobial	Bacillus subtilis	NUGC-3	Stomach Cancer	Sulforhodamine B assay	GI₅₀ = 13.9 µg/mL	48-h	Stomach	None
5070	24492520	2014	ELLVDLL	Gageostatin B	7	Linear	L	None	Free	3-beta-hydroxy-9,11-dimethyltridecanoic acid	Antimicrobial	Bacillus subtilis	PC-3	Prostate Cancer	Sulforhodamine B assay	GI₅₀ = 19.4 µg/mL	48-h	Prostate	None
5071	24492520	2014	ELLVDLL	Gageostatin B	7	Linear	L	None	Free	3-beta-hydroxy-9,11-dimethyltridecanoic acid	Antimicrobial	Bacillus subtilis	NCI-H23	Lung Cancer	Sulforhodamine B assay	GI₅₀ = 11.7 µg/mL	48-h	Lung	None
5068	24492520	2014	ELLVDLL	Gageostatin B	7	Linear	L	None	Free	3-beta-hydroxy-9,11-dimethyltridecanoic acid	Antimicrobial	Bacillus subtilis	MDA-MB-231	Breast Cancer	Sulforhodamine B assay	GI₅₀ = 16.1 µg/mL	48-h	Breast	None
5069	24492520	2014	ELLVDLL	Gageostatin B	7	Linear	L	None	Free	3-beta-hydroxy-9,11-dimethyltridecanoic acid	Antimicrobial	Bacillus subtilis	HCT-15	Colon Cancer	Sulforhodamine B assay	GI₅₀ = 18.3 µg/mL	48-h	Colon	None
5067	24492520	2014	ELLVDLL	Gageostatin A	7	Linear	L	None	Free	3-beta-hydroxy-11-methyltridecanoic acid	Antimicrobial	Bacillus subtilis	ACHN	Renal Cancer	Sulforhodamine B assay	GI₅₀ = 11.5 µg/mL	48-h	Kidney	None
5065	24492520	2014	ELLVDLL	Gageostatin A	7	Linear	L	None	Free	3-beta-hydroxy-11-methyltridecanoic acid	Antimicrobial	Bacillus subtilis	NCI-H23	Lung Cancer	Sulforhodamine B assay	GI₅₀ = 11.2 µg/mL	48-h	Lung	None
5066	24492520	2014	ELLVDLL	Gageostatin A	7	Linear	L	None	Free	3-beta-hydroxy-11-methyltridecanoic acid	Antimicrobial	Bacillus subtilis	NUGC-3	Stomach Cancer	Sulforhodamine B assay	GI₅₀ = 11.8 µg/mL	48-h	Stomach	None
5064	24492520	2014	ELLVDLL	Gageostatin A	7	Linear	L	None	Free	3-beta-hydroxy-11-methyltridecanoic acid	Antimicrobial	Bacillus subtilis	PC-3	Prostate Cancer	Sulforhodamine B assay	GI₅₀ = 10.8 µg/mL	48-h	Prostate	None
5063	24492520	2014	ELLVDLL	Gageostatin A	7	Linear	L	None	Free	3-beta-hydroxy-11-methyltridecanoic acid	Antimicrobial	Bacillus subtilis	HCT-15	Colon Cancer	Sulforhodamine B assay	GI₅₀ = 11.4 µg/mL	48-h	Colon	None
5062	24492520	2014	ELLVDLL	Gageostatin A	7	Linear	L	None	Free	3-beta-hydroxy-11-methyltridecanoic acid	Antimicrobial	Bacillus subtilis	MDA-MB-231	Breast Cancer	Sulforhodamine B assay	GI₅₀ = 14.9 µg/mL	48-h	Breast	None
5061	24830845	2014	ETFADWWKLLAE	mt_S20A/L22 W/P27A	12	Linear	L	None	Free	Free	Anticancer	MDM5	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀= 8.7 µM	Not Available	Breast	None
5060	24830845	2014	ESFSDWWKLLAE	mt_T18S/L22 W/P27A	12	Linear	L	None	Free	Free	Anticancer	MDM4	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=27 µM	Not Available	Breast	None
5059	24830845	2014	LTFSDWWKLLAE	mt_E17L/L22 W/P27A	12	Linear	L	None	Free	Free	Anticancer	MDM3	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=15.1 µM	Not Available	Breast	None
5058	24830845	2014	ETFSDWWKLLAE	mt_L22 W/P27A	12	Linear	L	None	Free	Free	Anticancer	MDM2	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=16.3 µM	Not Available	Breast	None
5057	24714081	2014	TKPRKTKPRKTKPRKTKPR	T Peptide	19	Linear	L	None	Free	Free	Anticancer	Tuftsin derivative	BGC-823	Gastric Cancer	MTT/MTS assay	67.2% maximum inhibitory rate at 8 mg/kg	48-h	Stomach	None
5056	24714081	2014	TKPRKTKPRKTKPRKTKPR	T Peptide	19	Linear	L	None	Free	Free	Anticancer	Tuftsin derivative	HT-29	Colon Cancer	MTT/MTS assay	70% maximum inhibitory rate at 8 mg/kg	48-h	Colon	None
5055	24714081	2014	TKPRKTKPRKTKPRKTKPR	T Peptide	19	Linear	L	None	Free	Free	Anticancer	Tuftsin derivative	HepG-2	Liver Cancer	MTT/MTS assay	69.6% maximum inhibitory rate at 8 mg/kg	48-h	Liver	None
5054	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC107	Colorectal Cancer	Cell Viability assay	Cell viability >70% at 12.5μM approx	24-h	Colon	None
5053	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC107	Colorectal Cancer	Cell Viability assay	Cell viability >65% at 12.5μM approx	24-h	Colon	None
5052	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC107	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 12.5μM approx	24-h	Colon	None
5051	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC32	Colorectal Cancer	Cell Viability assay	Cell viability >85% at 12.5μM approx	24-h	Colon	None
5050	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC32	Colorectal Cancer	Cell Viability assay	Cell viability >80% at 12.5μM approx	24-h	Colon	None
5049	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC32	Colorectal Cancer	Cell Viability assay	Cell viability >55% at 12.5μM approx	24-h	Colon	None
5048	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC113	Colorectal Cancer	Cell Viability assay	Cell viability >70% at 12.5μM approx	24-h	Colon	None
5047	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC113	Colorectal Cancer	Cell Viability assay	Cell viability >65% at 12.5μM approx	24-h	Colon	None
5046	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC113	Colorectal Cancer	Cell Viability assay	Cell viability >80% at 12.5μM approx	24-h	Colon	None
5045	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC60	Colorectal Cancer	Cell Viability assay	Cell viability >70% at 12.5μM approx	24-h	Colon	None
5044	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC60	Colorectal Cancer	Cell Viability assay	Cell viability >60% at 12.5μM approx	24-h	Colon	None
5043	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC60	Colorectal Cancer	Cell Viability assay	Cell viability >70% at 12.5μM approx	24-h	Colon	None
5042	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC40	Colorectal Cancer	Cell Viability assay	Cell viability >85% at 12.5μM approx	24-h	Colon	None
5041	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC40	Colorectal Cancer	Cell Viability assay	Cell viability >80% at 12.5μM approx	24-h	Colon	None
5040	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC40	Colorectal Cancer	Cell Viability assay	Cell viability >45% at 12.5μM approx	24-h	Colon	None
5039	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC24	Colorectal Cancer	Cell Viability assay	Cell viability >70% at 12.5μM approx	24-h	Colon	None
5038	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC24	Colorectal Cancer	Cell Viability assay	Cell viability >55% at 12.5μM approx	24-h	Colon	None
5037	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC24	Colorectal Cancer	Cell Viability assay	Cell viability >55% at 12.5μM approx	24-h	Colon	None
5036	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC18	Colorectal Cancer	Cell Viability assay	Cell viability >75% at 12.5μM approx	24-h	Colon	None
5035	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC18	Colorectal Cancer	Cell Viability assay	Cell viability >55% at 12.5μM approx	24-h	Colon	None
5034	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC18	Colorectal Cancer	Cell Viability assay	Cell viability >55% at 12.5μM approx	24-h	Colon	None
5033	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HCT-116	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 12.5μM approx	24-h	Colon	None
5032	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HCT-116	Colorectal Cancer	Cell Viability assay	Cell viability >40% at 12.5μM approx	24-h	Colon	None
5031	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HCT-116	Colorectal Cancer	Cell Viability assay	Cell viability >40% at 12.5μM approx	24-h	Colon	None
5030	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC32	Colorectal Cancer	Cell Viability assay	Cell viability =50% at 12.5μM approx.	1-h	Colon	None
5029	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC32	Colorectal Cancer	Cell Viability assay	Cell viability =50% at 12.5μM approx.	1-h	Colon	None
5028	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC32	Colorectal Cancer	Cell Viability assay	Cell viability >60% at 25μM approx	1-h	Colon	None
5027	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC60	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5026	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC60	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5025	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC60	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5024	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC40	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5023	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC40	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5022	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC40	Colorectal Cancer	Cell Viability assay	Cell viability >60% at 25μM approx	1-h	Colon	None
5021	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC24	Colorectal Cancer	Cell Viability assay	Cell viability >60% at 25μM approx	1-h	Colon	None
5020	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC24	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5019	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC24	Colorectal Cancer	Cell Viability assay	Cell viability >60% at 25μM approx	1-h	Colon	None
5018	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HCT-116	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 12.5μM approx.	1-h	Colon	None
5017	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HCT-116	Colorectal Cancer	Cell Viability assay	Cell viability =50% at 12.5μM approx.	1-h	Colon	None
5015	24676901	2014	KAQ-Dip-QKQAW	LTX-328	8	Linear	L	Dip = diphenylalanine	Amidation	Free	Antimicrobial	Synthetic peptide	Fem-X	Skin Cancer	MTT/MTS assay	IC₅₀= >350 µM	5–60 Min	Skin	None
5016	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HCT-116	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5013	24676901	2014	KKWWKKW-Dip-K	LTX-315	9	Linear	L	Dip = diphenylalanine	Amidation	Free	Antimicrobial	Synthetic peptide	A375	Skin Cancer	MTT/MTS assay	IC₅₀=12.7 µM	30-Min	Skin	None
5014	24676901	2014	KKWWKKW-Dip-K	LTX-315	9	Linear	L	Dip = diphenylalanine	Amidation	Free	Antimicrobial	Synthetic peptide	Fem-X	Skin Cancer	MTT/MTS assay	IC₅₀=15.3 µM	30-Min	Skin	None
5012	24676901	2014	KKWWKKW-Dip-K	LTX-315	9	Linear	L	Dip = diphenylalanine	Amidation	Free	Antimicrobial	Synthetic peptide	B16F1	Skin Cancer	MTT/MTS assay	IC₅₀=13.3 µM	30-Min	Skin	None
5011	24661024	2014	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Free	Free	Antimicrobial	Main component of honey bee venom	SCC25	Skin Cancer	Cell Viability assay	102.9 ± 4.1% cell growth inhibition at 1 µM	24-h	Skin	None
5010	24661024	2014	KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK	Cecropin A	37	Linear	L	None	Free	Free	Antimicrobial	Isolated from the giant silk moth Hyalophora cecropia	SCC25	Skin Cancer	Cell Viability assay	107.0 ± 5.0% cell growth inhibition at 1 µM	24-h	Skin	None
5009	24661024	2014	KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK	Cecropin A	37	Linear	L	None	Free	Free	Antimicrobial	Isolated from the giant silk moth Hyalophora cecropia	SCC25	Skin Cancer	Cell Viability assay	0.6 ± 0.6% cell growth inhibition at 10 µM	48-h	Skin	None
5008	24661024	2014	KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK	Cecropin A	37	Linear	L	None	Free	Free	Antimicrobial	Isolated from the giant silk moth Hyalophora cecropia	SCC25	Skin Cancer	MTT/MTS assay	IC₅₀=2.2 µM	48-h	Skin	None
5007	24661024	2014	KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK	Cecropin A	37	Linear	L	None	Free	Free	Antimicrobial	Isolated from the giant silk moth Hyalophora cecropia	SCC12	Skin Cancer	MTT/MTS assay	IC₅₀=1 µM	48-h	Skin	None
5006	24587350	2014	LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	LL 37	37	Linear	L	None	Free	Free	Antimicrobial	Also known human cathelicidin	OVRCAR-3	Ovarian Cancer	MTT/MTS assay	LC₅₀= 24 at 100 µM	72-h	Ovary	None
5005	24587350	2014	GIGKFLKKAKKFGKAFVKILKK	Pexiganan	22	Linear	L	None	Amidation	Free	Antimicrobial	Analog of magainin 2	OVRCAR-3	Ovarian Cancer	MTT/MTS assay	LC₅₀= 13 at 100 µM	72-h	Ovary	None
5004	24587350	2014	LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	LL 37	37	Linear	L	None	Free	Free	Antimicrobial	Also known human cathelicidin	LNCaP	Prostate cancer	MTT/MTS assay	LC₅₀= 27 at 100 µM	72-h	Prostate	None
5003	24587350	2014	GIGKFLKKAKKFGKAFVKILKK	Pexiganan	22	Linear	L	None	Amidation	Free	Antimicrobial	Analog of magainin 2	LNCaP	Prostate cancer	MTT/MTS assay	LC₅₀= 6 at 100 µM	72-h	Prostate	None
5002	24587350	2014	LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	LL 37	37	Linear	L	None	Free	Free	Antimicrobial	Also known human cathelicidin	MCF-7	Breast Cancer	MTT/MTS assay	LC₅₀= 21 at 100 µM	72-h	Breast	None
5001	24587350	2014	GIGKFLKKAKKFGKAFVKILKK	Pexiganan	22	Linear	L	None	Amidation	Free	Antimicrobial	Analog of magainin 2	MCF-7	Breast Cancer	MTT/MTS assay	LC₅₀= 8 at 100 µM	72-h	Breast	None
4673	22885172	2012	GLFGKLIKKFARKAISYAVKKARGKH	ltc2aG11A	26	Linear	L	None	Free	Free	Antimicrobial	Central Asian spider, Lachesana tarabaevi	Prostate tumor cellline	Prostate Cancer	LDH leakage assay	graph fig 8 A	Not Available	Prostate	None
4671	23085771	2012	Not Available	12c	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=14 µM	Not Available	Blood	None
4672	22885172	2012	GLFGKLIKKFGRKAISYAVKKARGKH	Latarcin 2a	26	Linear	L	None	Free	Free	Antimicrobial	Central Asian spider, Lachesana tarabaevi	Breast tumor cellline	Breast Cancer	LDH leakage assay	graph fig 8 A	Not Available	Breast	None
4669	23085771	2012	Not Available	12a	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=6.1 µM	Not Available	Blood	None
4670	23085771	2012	Not Available	12b	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=27 µM	Not Available	Blood	None
4667	23085771	2012	Not Available	11b	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=19 µM	Not Available	Blood	None
4668	23085771	2012	Not Available	11c	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=7.2 µM	Not Available	Blood	None
4666	23085771	2012	Not Available	11a	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=5.2 µM	Not Available	Blood	None
4664	23085771	2012	Not Available	10b	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=11.4 µM	Not Available	Blood	None
4665	23085771	2012	Not Available	10c	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=6.6 µM	Not Available	Blood	None
4662	23085771	2012	Not Available	9c	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=3.1 µM	Not Available	Blood	None
4663	23085771	2012	Not Available	10a	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=28 µM	Not Available	Blood	None
4660	23085771	2012	Not Available	9a	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=31 µM	Not Available	Blood	None
4661	23085771	2012	Not Available	9b	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=2.3 µM	Not Available	Blood	None
4658	23085771	2012	Not Available	8b	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=>254 µM	Not Available	Blood	None
4659	23085771	2012	Not Available	8c	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=107 µM	Not Available	Blood	None
4657	23085771	2012	Not Available	8a	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=136 µM	Not Available	Blood	None
4655	23085771	2012	Not Available	7b	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=>78 µM	Not Available	Blood	None
4656	23085771	2012	Not Available	7c	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=79 µM	Not Available	Blood	None
4653	23085771	2012	Not Available	6c	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=4.3 µM	Not Available	Blood	None
4654	23085771	2012	Not Available	7a	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=>63 µM	Not Available	Blood	None
4650	23085771	2012	Not Available	5c	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=4.1 µM	Not Available	Blood	None
4651	23085771	2012	Not Available	6a	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=14.4 µM	Not Available	Blood	None
4652	23085771	2012	Not Available	6b	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=11.0 µM	Not Available	Blood	None
4648	23085771	2012	Not Available	5a	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=10.6 µM	Not Available	Blood	None
4649	23085771	2012	Not Available	5b	3	Linear	L	None	Free	Free	Antimicrobial	synthetic b2,2-amino acid derivatives	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀=7.1 µM	Not Available	Blood	None
4600	21351323	2011	YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK	EGFR-lytic	32	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	MDA-MB-231	Breast Cancer	ELISA	IC₅₀ =0.46 µM	15-Min	Breast	None
4599	21351323	2011	YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK	EGFR-lytic	32	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	MDA-MB-231	Breast Cancer	ELISA	IC₅₀ =0.12 µM	60-Min	Breast	None
4598	21403917	2011	FLPLIGRVLSGIL	Temporin A	13	Linear	L	None	Amidation	Free	Antimicrobial	Frog Rana temporaria	U-943	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =80-90 µg/ml	Not Available	Blood	None
4597	21403917	2011	RGGRLCYCRRRFCVCVGR	Protegrin 1	18	Linear	L	None	Amidation	Free	Antimicrobial	alpha helical peptide without cysteines	U-942	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =30-40 µg/ml	Not Available	Blood	None
4596	21403917	2011	GIGKFLKKAKKFGKAFVKILKK	Pexiganan MSI-78	18	Linear	L	None	Amidation	Free	Antimicrobial	Analog of Magainin	U-941	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =20-30 µg/ml	Not Available	Blood	None
4595	21403917	2011	ILRWPWWPWRRK	Omiganan MBI-226	12	Linear	L	None	Amidation	Free	Antimicrobial	Bovine neutrophils	U-937	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =80-85 µg/ml	Not Available	Blood	None
4594	21403917	2011	AKRHHGYKRKFH	Demegen P-113	12	Linear	L	None	Amidation	Free	Antimicrobial	Canaida albicans	U-939	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =85-90 µg/ml	Not Available	Blood	None
4593	21403917	2011	GLFDVIKKVASVIGGL	Citropin 1.1	16	Linear	L	None	Amidation	Free	Antimicrobial	Australian blue mountains tree frog, Litoria citropa	U-938	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =40 µg/ml	Not Available	Blood	None
4592	21403917	2011	TRSSRAGLQFPVGRVHRLLRK	Buforin 2	21	Linear	L	None	Free	Free	Antimicrobial	Bufo Bufo Gargarizans	U-937	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =90-95 µg/ml	Not Available	Blood	None
4591	21423613	2011	QETFSDLWKLLP	P5317-28	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =30 µM	Not Available	Colon	None
4590	21423613	2011	LTAEHYAAQATS	3A	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ >100 µM	Not Available	Colon	None
4588	21423613	2011	PRFWEYWLRLME	MIP	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =0.12 µM	Not Available	Colon	None
4589	21423613	2011	LTFEHYWAQLTS	DI	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =1.6 µM	Not Available	Colon	None
4587	21423613	2011	PRFWEYWLRLAE	MIP(M11A)	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =0.4 µM	Not Available	Colon	None
4585	21423613	2011	PRFWEYWLALME	MIP(R9A)	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =0.02 µM	Not Available	Colon	None
4586	21423613	2011	PRFWEYWLRAME	MIP(L10A)	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =1.14 µM	Not Available	Colon	None
4584	21423613	2011	PRFWEYALRLME	MIP(W7A)	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ >100 µM	Not Available	Colon	None
4583	21423613	2011	PRFWEAWLRLME	MIP(Y6A)	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ >100 µM	Not Available	Colon	None
4582	21423613	2011	PRAWEYWLRLME	MIP(F3A)	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =0.57 µM	Not Available	Colon	None
4580	21423613	2011	LTAEHYAAQATS	3A	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ >100 µM	Not Available	Colon	None
4581	21423613	2011	QETFSDLWKLLP	P5317-28	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =4.7 µM	Not Available	Colon	None
4579	21423613	2011	LTFEHYWAQLTS	DI	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =0.29 µM	Not Available	Colon	None
4577	21928125	2012	GVGSPYVSRLLGICL	p776	15	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	Not Available	Tumor	ELISPOT assay	Not Available	Not Available	Not Available	None
4578	21423613	2011	PRFWEYWLRLME	MIP	12	Linear	L	None	Free	Free	Antitumor	E3 ubiquitin-protein ligase	HCT-116-p53+/+	Colon Cancer	Immunoprecipitation assay	IC₅₀ =0.01 µM	Not Available	Colon	None
4575	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MCF-7-TX400	Breast Cancer	MTT/MTS assay	~5% cytotoxic at 50 µM	24-h	Breast	None
4576	21928125	2012	LIAHNQVRQV	p85	10	Linear	L	None	Free	Free	Antitumor	Synthetic Peptide	Not Available	Tumor	ELISPOT assay	Not Available	Not Available	Not Available	None
4574	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MCF-7-TX400	Breast Cancer	MTT/MTS assay	60-70% cytotoxic at 50 µM	24-h	Breast	None
4571	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MCF-7	Breast Cancer	MTT/MTS assay	70% cytotoxic at 50 µM	24-h	Breast	None
4572	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MCF-7	Breast Cancer	MTT/MTS assay	0% cytotoxic at 50 µM	24-h	Breast	None
4573	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MCF-7-TX400	Breast Cancer	MTT/MTS assay	60-70% cytotoxic at 50 µM	24-h	Breast	None
4567	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 10 µM	24-h	Breast	None
4568	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	5-10% cytotoxic at 25 µM	24-h	Breast	None
4569	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	20% cytotoxic at 50 µM	24-h	Breast	None
4570	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MCF-7	Breast Cancer	MTT/MTS assay	70% cytotoxic at 50 µM	24-h	Breast	None
4564	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	5% cytotoxic at 25 µM	24-h	Breast	None
4565	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	10-15% cytotoxic at 50 µM	24-h	Breast	None
4566	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 5 µM	24-h	Breast	None
4561	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	15-20% cytotoxic at 50 µM	24-h	Breast	None
4562	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	~5% cytotoxic at 5 µM	24-h	Breast	None
4563	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	~5% cytotoxic at 10 µM	24-h	Breast	None
4559	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	10% cytotoxic at 10 µM	24-h	Breast	None
4560	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	10-15% cytotoxic at 25 µM	24-h	Breast	None
4557	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	10-15% cytotoxic at 50 µM	24-h	Breast	None
4558	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	10% cytotoxic at 5 µM	24-h	Breast	None
4555	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 10 µM	24-h	Breast	None
4556	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	10% cytotoxic at 25 µM	24-h	Breast	None
4552	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	10% cytotoxic at 25 µM	24-h	Breast	None
4553	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	10-15% cytotoxic at 50 µM	24-h	Breast	None
4554	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 5 µM	24-h	Breast	None
4549	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	80-90% cytotoxic at 25 µM	24-h	Breast	None
4550	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	85-90% cytotoxic at 50 µM	24-h	Breast	None
4551	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	~5% cytotoxic at 10 µM	24-h	Breast	None
4546	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	80-90% cytotoxic at 50 µM	24-h	Breast	None
4547	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	30-40% cytotoxic at 5 µM	24-h	Breast	None
4548	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	60-70% cytotoxic at 10 µM	24-h	Breast	None
4544	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	50% cytotoxic at 10 µM	24-h	Breast	None
4545	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	80% cytotoxic at 25 µM	24-h	Breast	None
4543	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	10% cytotoxic at 5 µM	24-h	Breast	None
4540	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	20% cytotoxic at 10 µM	24-h	Breast	None
4541	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	70-80% cytotoxic at 25 µM	24-h	Breast	None
4542	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	80-85% cytotoxic at 50 µM	24-h	Breast	None
4538	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	40-50% cytotoxic at 50 µM	24-h	Breast	None
4539	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 5 µM	24-h	Breast	None
4537	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	20% cytotoxic at 25 µM	24-h	Breast	None
4534	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	40-50% cytotoxic at 50 µM	24-h	Breast	None
4535	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 5 µM	24-h	Breast	None
4536	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	10% cytotoxic at 10 µM	24-h	Breast	None
4532	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	5% cytotoxic at 10 µM	24-h	Breast	None
4533	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	20-30% cytotoxic at 25 µM	24-h	Breast	None
4530	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	85-90% cytotoxic at 50 µM	24-h	Breast	None
4531	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 5 µM	24-h	Breast	None
4528	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	40-50% cytotoxic at 10 µM	24-h	Breast	None
4529	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	80% cytotoxic at 25 µM	24-h	Breast	None
4525	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	60-70% cytotoxic at 25 µM	24-h	Breast	None
4526	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	80-85% cytotoxic at 50 µM	24-h	Breast	None
4527	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	15-20% cytotoxic at 5 µM	24-h	Breast	None
4524	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	40-50% cytotoxic at 10 µM	24-h	Breast	None
4521	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	70% cytotoxic at 25 µM	24-h	Breast	None
4522	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	80-85% cytotoxic at 50 µM	24-h	Breast	None
4523	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	30% cytotoxic at 5 µM	24-h	Breast	None
4520	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	50% cytotoxic at 10 µM	24-h	Breast	None
4518	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	60% cytotoxic at 50 µM	24-h	Breast	None
4519	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	30% cytotoxic at 5 µM	24-h	Breast	None
4517	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	30-35% cytotoxic at 25 µM	24-h	Breast	None
4515	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	5-10% cytotoxic at 5 µM	24-h	Breast	None
4516	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	10% cytotoxic at 10 µM	24-h	Breast	None
4514	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	60% cytotoxic at 50 µM	24-h	Breast	None
4511	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	5% cytotoxic at 5 µM	24-h	Breast	None
4512	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	5% cytotoxic at 10 µM	24-h	Breast	None
4513	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	30-35% cytotoxic at 25 µM	24-h	Breast	None
4504	22057278	2011	AAKKWAKAKWAKAKKWAKAA	Z10	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Colon	None
4503	22057278	2011	AAWKWAWAKKWAKAKKWAKAA	Z9	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ =13 µM	Not Available	Colon	None
4501	22057278	2011	KAAKKAWKAAKKAWKAAKKAA	Z7	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ =21 µM	Not Available	Colon	None
4502	22057278	2011	AWKKWAKAWKWAKAKWWAKAA	Z8	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ =23 µM	Not Available	Colon	None
4500	22057278	2011	KWWKKAAKAAKKAAKAAKKWA	Z6	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ =31 µM	Not Available	Colon	None
4499	22057278	2011	KAAKKAWKWAKKAAKWAKKAA	Z5	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ =67 µM	Not Available	Colon	None
4498	22057278	2011	KAAKKAWKAAKKAAKWWKKAA	Z4	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ =173 µM	Not Available	Colon	None
4497	22057278	2011	KAAKKAWKAWKKAAKAAWKKAA	Z3	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Colon	None
4496	22057278	2011	KAAKKWAKAWKKAAKAWKKAA	Z2	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Colon	None
4495	22057278	2011	KAAKKWAKAAKKWAKAWKKAA	Z1	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Colon	None
4494	22057278	2011	AAKKWAKAKWAKAKKWAKAA	Z10	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Breast	None
4493	22057278	2011	AAWKWAWAKKWAKAKKWAKAA	Z9	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =16 µM	Not Available	Breast	None
4492	22057278	2011	AWKKWAKAWKWAKAKWWAKAA	Z8	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =14 µM	Not Available	Breast	None
4491	22057278	2011	KAAKKAWKAAKKAWKAAKKAA	Z7	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =15 µM	Not Available	Breast	None
4490	22057278	2011	KWWKKAAKAAKKAAKAAKKWA	Z6	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =16 µM	Not Available	Breast	None
4489	22057278	2011	KAAKKAWKWAKKAAKWAKKAA	Z5	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =28 µM	Not Available	Breast	None
4488	22057278	2011	KAAKKAWKAAKKAAKWWKKAA	Z4	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =68 µM	Not Available	Breast	None
4487	22057278	2011	KAAKKAWKAWKKAAKAAWKKAA	Z3	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =128 µM	Not Available	Breast	None
4486	22057278	2011	KAAKKWAKAWKKAAKAWKKAA	Z2	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =173 µM	Not Available	Breast	None
4485	22057278	2011	KAAKKWAKAAKKWAKAWKKAA	Z1	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =186 µM	Not Available	Breast	None
4484	22057278	2011	AAKKWAKAKWAKAKKWAKAA	Z10	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Skin	None
4483	22057278	2011	AAWKWAWAKKWAKAKKWAKAA	Z9	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ =9 µM	Not Available	Skin	None
4482	22057278	2011	AWKKWAKAWKWAKAKWWAKAA	Z8	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ =19 µM	Not Available	Skin	None
4481	22057278	2011	KAAKKAWKAAKKAWKAAKKAA	Z7	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ =15 µM	Not Available	Skin	None
4480	22057278	2011	KWWKKAAKAAKKAAKAAKKWA	Z6	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ =17 µM	Not Available	Skin	None
4479	22057278	2011	KAAKKAWKWAKKAAKWAKKAA	Z5	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ =42 µM	Not Available	Skin	None
4478	22057278	2011	KAAKKAWKAAKKAAKWWKKAA	Z4	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ =155 µM	Not Available	Skin	None
4477	22057278	2011	KAAKKAWKAWKKAAKAAWKKAA	Z3	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Skin	None
4476	22057278	2011	KAAKKWAKAWKKAAKAWKKAA	Z2	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Skin	None
4475	22057278	2011	KAAKKWAKAAKKAAKAWKKAA	Z1	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Skin	None
4474	22076954	2011	RRRRRRRRGGC-Pem	Peptide-3	11	Linear	L	Pem= Pemetrexed	Amidation	Free	Anticancer	Synthetic	NCI-H358	Lung Cancer	MTT/MTS assay	IC₅₀ = 8.41 µM	3-h	Lung	None
4473	22076954	2011	IELLQARGGC-Pem-GGRRRRRRRR	Peptide-2	20	Linear	L	Pem= Pemetrexed	Amidation	Free	Anticancer	Synthetic	NCI-H358	Lung Cancer	MTT/MTS assay	IC₅₀ = 2.19 µM	3-h	Lung	None
4472	22076954	2011	IELLQARGGC-Pem	Peptide-1	10	Linear	L	Pem= Pemetrexed	Amidation	Free	Anticancer	Synthetic	NCI-H358	Lung Cancer	MTT/MTS assay	IC₅₀ = 4.63 mM	3-h	Lung	None
4471	22076954	2011	RRRRRRRRGGC-Pem	Peptide-3	11	Linear	L	Pem= Pemetrexed	Amidation	Free	Anticancer	Synthetic	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 6.24 µM	3-h	Blood	None
4470	22076954	2011	IELLQARGGC-Pem-GGRRRRRRRR	Peptide-2	10	Linear	L	Pem= Pemetrexed	Amidation	Free	Anticancer	Synthetic	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 2.64 µM	3-h	Blood	None
4469	22076954	2011	IELLQARGGC-Pem	Peptide-1	10	Linear	L	Pem= Pemetrexed	Amidation	Free	Anticancer	Synthetic	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 2.17 µM	3-h	Blood	None
4427	21434649, 18957441	2011	GLPVCGETCFGGTCNTPGCTCDPWPVCTRN	Vaby D	30	Not Available	L	None	Free	Free	Anticancer	African, the Ethiopian highlands, Viola abyssinica	Not Available	Fibrosarcoma	Not Available	Not Available	Not Available	Fibrous connective tissue	None
4426	21434649, 18957441	2011	GLPVCGETCAGGTCNTPGCSCSWPICTRN	Vaby A	29	Not Available	L	None	Free	Free	Anticancer	African, the Ethiopian highlands, Viola abyssinica	Not Available	Fibrosarcoma	Not Available	Not Available	Not Available	Fibrous connective tissue	None
4416	22771617, 18957441	2012	GLLGLLGSVVSHVVPAIVGHF	Maculatin 1.3	21	Not Available	L	None	Free	Free	Anticancer	Blue-thighed frog,Litoria chloris, Australia	Not Available	Skin Cancer	Not Available	Not Available	Not Available	Not Available	None
4415	22771617, 18957441	2012	GLLGLLGSVVSHVLPAITQHL	Maculatin 1.4	21	Not Available	L	None	Free	Free	Anticancer	Blue-thighed frog,Litoria chloris, Australia	Not Available	Skin Cancer	Not Available	Not Available	Not Available	Not Available	None
4387	22100226, 18957441	2012	GFGMALKLLKKVL	Macropin 1	13	Not Available	L	None	Free	Free	Antibacterial	Venom, the solitary beeMacropis fulvipes	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4386	22100226, 18957441	2012	GTGLPMSERRKIMLMMR	Macropin 2	17	Not Available	L	None	Free	Free	Antibacterial	Venom, the solitary beeMacropis fulvipes	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4384	21596752, 18957441	2011	GEFLKCGESCVQGECYTPGCSCDWPICKKN	Cliotide T2	30	Not Available	L	None	Free	Free	Antibacterial	Clitoria ternatea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4383	21596752, 18957441	2011	GIPCGESCVFIPCITAAIGCSCKSKVCYRN	Cliotide T4	30	Not Available	L	None	Free	Free	Antibacterial	Clitoria ternatea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4382	21596752, 18957441	2011	GIPCGESCVFIPCITGAIGCSCKSKVCYRN	Cliotide T1	30	Not Available	L	None	Free	Free	Antibacterial	Clitoria ternatea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4381	21596752, 18957441	2011	GLPTCGETCTLGTCYVPDCSCSWPICMKN	Cliotide T3	29	Not Available	L	None	Free	Free	Antibacterial	Clitoria ternatea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4379	21723349, 18957441	2011	GSIPCEGSCVFIPCISAIIGCSCSNKVCYKN	Viphi G	31	Not Available	L	None	Free	Free	Antibacterial	Viola philippica	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4378	21723349, 18957441	2011	GLPVCGETCVGGTCNTPGCGCSWPVCTRN	Viba17	29	Not Available	L	None	Free	Free	Antibacterial	Viola philippica	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4377	21723349, 18957441	2011	GLPVCGETCVGGTCNTPGCACSWPVCTRN	Viba 15	29	Not Available	L	None	Free	Free	Antibacterial	Viola philippica	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4376	21723349, 18957441	2011	GIPCGESCVFIPCLTSAIDCSCKSKVCYRN	Mram 8	30	Not Available	L	None	Free	Free	Antibacterial	Viola philippica	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4375	21723349, 18957441	2011	GSIPCGESCVFIPCISAIIGCSCSSKVCYKN	Viphi F	31	Not Available	L	None	Free	Free	Antibacterial	Viola philippica	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4374	21723349, 18957441	2011	GSIPCGESCVFIPCISSVIGCACKSKVCYKN	Viphi F	31	Not Available	L	None	Free	Free	Antibacterial	Viola philippica	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4373	21723349, 18957441	2011	GSIPCGESCVFIPCISAVIGCSCSNKVCYKN	Viphi E	31	Not Available	L	None	Free	Free	Antibacterial	Viola philippica	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4372	22467870, 18957441	2012	GIPCAESCVWIPPCTITALMGCSCKNNVCYNN	Chassatide C2	32	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4371	22467870, 18957441	2012	GEYCGESCYLIPCFTPGCYCVSRQCVNKN	Chassatide C10	29	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4370	22467870, 18957441	2012	GDACGETCFTGICFTAGCSCNPWPTCTRN	Chassatide C4	29	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4369	22467870, 18957441	2012	GASCGETCFTGICFTAGCSCNPWPTCTRN	Chassatide C4	29	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4368	22467870, 18957441	2012	IPCGESCVWIPCISGMFGCSCKDKVCYS	ChaC11	29	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4367	22467870, 18957441	2012	AIPCGESCVWIPCISTVIGCSCSNKVCYR	Chassatide C8	29	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4366	22467870, 18957441	2012	IPCGESCVWIPCITAIAGCSCKNKVCYT	ChaC7	29	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4365	21882228, 18957441	2012	AWKLFDDGV	Cr-ACP1	9	Not Available	L	None	Free	Free	Antibacterial	Seeds,Cycas revoluta	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
3828	23034893	2012	MDSNKDERAYAQWVIIILHNVGSSPFKIANLGLSWGKLYADGNKDKEVYP SDYNGKTVGPDEKIQINSCGRENASSGTEGSFDIVDPNDGNKTIRHFYWECPWGS KRNTWTPSGSNTKWMVEWSGQNLDSGALGTITVDVLRKGN	AAD (or Aa-Pri1)	145	Linear	L	None	Free	Free	Antitumor	Purified from Agrocybe aegerita	SH-SY5Y	Brain Tumor	MTT/MTS assay	At 2.5 µM concentration,decrease in cell vibility= 70%	48-h	Brain	None
3827	23034893	2012	MDSNKDERAYAQWVIIILHNVGSSPFKIANLGLSWGKLYADGNKDKEVYP SDYNGKTVGPDEKIQINSCGRENASSGTEGSFDIVDPNDGNKTIRHFYW ECPWGSKRNTWTPSGSNTKWMVEWSGQNLDSGALGTITVDVLRKGN	AAD (or Aa-Pri1)	145	Linear	L	None	Free	Free	Antitumor	Purified from Agrocybe aegerita	HeLa	Cervical Cancer	MTT/MTS assay	At 2.5 µM concentration,decrease in cell vibility= 70%	48-h	Cervix	None
3826	23034893	2012	MDSNKDERAYAQWVIIILHNVGSSPFKIANLGLSWGKLYADGNKDKEVY PSDYNGKTVGPDEKIQINSCGRENASSGTEGSFDIVDPNDGNKTIRHFYW ECPWGSKRNTWTPSGSNTKWMVEWSGQNLDSGALGTITVDVLRKGN	AAD (or Aa-Pri1)	145	Linear	L	None	Free	Free	Antitumor	Purified from Agrocybe aegerita	HepG-2	Liver Cancer	MTT/MTS assay	At 2.5 µM concentration,decrease in cell vibility= 35%	48-h	Liver	None
3824	22963485	2012	MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNF VLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQL	RGD-mda-7	207	Linear	L	None	Free	Free	Anticancer	Derived from wtmda-7/IL-24 by insertion og a glycine residue between Arg(164) and Asp(165).	Ket-3	Tumor	MTT assay	Apoptotic rate(%)= >50% at concentration of 8 µg/ml	72-h	Not Available	None
3823	22963485	2012	MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNF VLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAFK QLDVEAALTKALGEVDILLTWMQKFYKL	RGD-mda-7	207	Linear	L	None	Free	Free	Anticancer	Derived from wtmda-7/IL-24 by insertion og a glycine residue between Arg(164) and Asp(165).	MCF-7	Breast Cancer	MTT assay	Apoptotic rate(%)= >70% at concentration of 8 µg/ml	72-h	Breast	None
3821	22963485	2012	MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNF VLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAF KQL	wtmda-7/IL-24	206	Linear	L	None	Free	Free	Anticancer	NA	Ket-3	Tumor	MTT assay	Apoptotic rate(%)= >30% at concentration of 8 µg/ml	72-h	Not Available	None
3820	22963485	2012	MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN FVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAF KQL	wtmda-7/IL-24	206	Linear	L	None	Free	Free	Anticancer	NA	MCF-7	Breast Cancer	MTT assay	Apoptotic rate(%)= >50% at concentration of 8 µg/ml	72-h	Breast	None
3819	22963485	2012	MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN FVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAF KQLDVEAALTKALGEVDILLTWMQKFYKL	RGD-mda-7	207	Linear	L	None	Free	Free	Anticancer	Derived from wtmda-7/IL-24 by insertion og a glycine residue between Arg(164) and Asp(165).	Ket-3	Tumor	MTT/MTS assay	Cell viability(% of control)= 0.5 at concentration 8 µg/ml	48-h	Not Available	None
3818	22963485	2012	MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN FVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAF KQLDVEAALTKALGEVDILLTWMQKFYKL	RGD-mda-7	207	Linear	L	None	Free	Free	Anticancer	Derived from wtmda-7/IL-24 by insertion og a glycine residue between Arg(164) and Asp(165).	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability(% of control)=0.5 at concentration 4 µg/ml	48-h	Breast	None
3817	22963485	2012	MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN FVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRA FKQL	wtmda-7/IL-24	206	Linear	L	None	Free	Free	Anticancer	NA	Ket-3	Tumor	MTT/MTS assay	Cell viability(% of control)= 0.5 at concentration 8 µg/ml	48-h	Not Available	None
3816	22963485	2012	MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLAN NFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRA FKQL	wtmda-7/IL-24	206	Linear	L	None	Free	Free	Anticancer	NA	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability(% of control)=0.5 at concentration 7 µg/ml	48-h	Breast	None
3815	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Anticancer	Natural component of bee venom	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 1.4±0.1 µM	24-h	Skin	None
3814	23893605	2013	KISKRILTGKK	NK-11	11	Linear	L	None	Amidation	Free	Anticancer	NK2 derived inactive control peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ >> 100 µM	24-h	Skin	None
3813	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A- Δ	23	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 13.1±0.9 µM	24-h	Skin	None
3812	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21k	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 12.3±1.0 µM	24-h	Skin	None
3811	23893605	2013	KILRGVAKKILRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 3.7± 4.3 µM	24-h	Skin	None
3810	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Anticancer	Residue of 39-65 of porcine NK-lysine	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 40 µM (approx)	24-h	Skin	None
3808	23893605	2013	KISKRILTGKK	NK-11	11	Linear	L	None	Amidation	Free	Anticancer	NK2 derived inactive control peptide	E42/02	Skin Cancer	MTT/MTS assay	IC-50 >> 100 µM	4-h	Skin	None
3809	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Anticancer	Natural component of bee venom	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 1.8±0.1 µM	4-h	Skin	None
3807	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A- Δ	23	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 9.3±1.5 µM	4-h	Skin	None
3806	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21k	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 8.3±0.5 µM	4-h	Skin	None
3805	23893605	2013	KILRGVAKKILRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 12.1±1.6 µM	4-h	Skin	None
3804	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Anticancer	Residue of 39-65 of porcine NK-lysine	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 50 µM (approx)	4-h	Skin	None
3803	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Anticancer	Natural component of bee venom	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 2.1±0.1 µM	2-h	Skin	None
3802	23893605	2013	KISKRILTGKK	NK-11	11	Linear	L	None	Amidation	Free	Anticancer	NK2 derived inactive control peptide	E42/02	Skin Cancer	MTT/MTS assay	IC-50 >> 100 µM	2-h	Skin	None
3801	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A- Δ	23	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 13.8±2.0 µM	2-h	Skin	None
3800	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21k	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 12.3±2.0 µM	2-h	Skin	None
3799	23893605	2013	KILRGVAKKILRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 13.0±1.0 µM	2-h	Skin	None
3798	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Anticancer	Residue of 39-65 of porcine NK-lysine	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 50 µM (approx)	2-h	Skin	None
3797	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Anticancer	Natural component of bee venom	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 3.2±0.1 µM	30-Min	Skin	None
3796	23893605	2013	KISKRILTGKK	NK-11	11	Linear	L	None	Amidation	Free	Anticancer	NK2 derived inactive control peptide	E42/02	Skin Cancer	MTT/MTS assay	IC-50>> 100 µM	30-Min	Skin	None
3795	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A- Δ	23	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 7.5±0.4 µM	30-Min	Skin	None
3794	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21k	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 8.4±0.2 µM	30-Min	Skin	None
3793	23893605	2013	KILRGVAKKILRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 10.6±0.4 µM	30-Min	Skin	None
3792	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Anticancer	Residue of 39-65 of porcine NK-lysine	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 70 µM (approx)	30-Min	Skin	None
3791	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Anticancer	Natural component of bee venom	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 1.4±0.1 µM	4-h	Skin	None
3790	23893605	2013	KISKRILTGKK	NK-11	11	Linear	L	None	Amidation	Free	Anticancer	NK2 derived inactive control peptide	E42/02	Skin Cancer	MTT/MTS assay	IC-50 >> 100 µM	4-h	Skin	None
3789	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Anticancer	Residue of 39-65 of porcine NK-lysine	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 4.3±0.3 µM	4-h	Skin	None
3788	22933412	2012	KW β2,2KK	c8	5	Linear	L	(2,2-di(4-[trifluoromethyl]benzyl)-3-amino-propionic acid)	Amidation	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 226±21 µMol/L	NA	Blood	None
3787	22933412	2012	KK β2,2WKK	c7	6	Linear	L	(2,2-di(4-[trifluoromethyl]benzyl)-3-amino-propionic acid)	Amidation	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 157±30 µMol/L	NA	Blood	None
3786	22933412	2012	KW β2,2WKK	c6	6	Linear	L	(2,2-di(4-[trifluoromethyl]benzyl)-3-amino-propionic acid)	Amidation	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 26±2 µMol/L	NA	Blood	None
3785	22933412	2012	KKW β2,2WKK	c5	7	Linear	L	(2,2-di(4-[trifluoromethyl]benzyl)-3-amino-propionic acid)	Amidation	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 23±3 µMol/L	NA	Blood	None
3784	22933412	2012	KW β2,2KK	c4	5	Linear	L	(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)	Amidation	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 99±15 µMol/L	NA	Blood	None
3783	22933412	2012	KK β2,2WKK	c3	6	Linear	L	(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)	Amidation	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 92±2 µMol/L	NA	Blood	None
3782	22933412	2012	KW β2,2WKK	c2	6	Linear	L	(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)	Amidation	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 1.71±0.6 µMol/L	NA	Blood	None
3781	22933412	2012	KKWβ2,2WKK	c1	7	Linear	L	(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)	Amidation	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 22±5 µMol/L	NA	Blood	None
3780	22933412	2012	KW β2,2KK	c8	5	Cyclic	L	(2,2-di(4-[trifluoromethyl]benzyl)-3-amino-propionic acid)	Free	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 20±2 µMol/L	NA	Blood	None
3779	22933412	2012	KK β2,2WKK	c7	6	Cyclic	L	(2,2-di(4-[trifluoromethyl]benzyl)-3-amino-propionic acid)	Free	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 16±5 µMol/L	NA	Blood	None
3778	22933412	2012	KW β2,2WKK	c6	6	Cyclic	L	(2,2-di(4-[trifluoromethyl]benzyl)-3-amino-propionic acid)	Free	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 8±1 µMol/L	NA	Blood	None
3775	22933412	2012	KK β2,2WKK	c3	6	Cyclic	L	(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)	Free	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 15±2 µMol/L	NA	Blood	None
3776	22933412	2012	KW β2,2KK	c4	5	Cyclic	L	(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)	Free	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 12.6±0.6 µMol/L	NA	Blood	None
3777	22933412	2012	KKW β2,2WKK	c5	7	Cyclic	L	(2,2-di(4-[trifluoromethyl]benzyl)-3-amino-propionic acid)	Free	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 11±2 µMol/L	NA	Blood	None
3773	22933412	2012	KKWβ2,2WKK	c1	7	Cyclic	L	(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)	Free	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 10±2 µMol/L	NA	Blood	None
3774	22933412	2012	KW β2,2WKK	c2	6	Cyclic	L	(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)	Free	Free	Anticancer	KKWβ2,2WKK	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀= 7.9±0.3 µMol/L	NA	Blood	None
3772	22837667	2012	KWKSFlKTFKSlKKTVlHTllKAISS	Peptide L6D/L12D/L17D/L20D/L21D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 12.88±0.15 µMol/L	1-h	Cervix	None
3771	22837667	2012	KWKSFlKTFKSlKKTVlHTlLKAISS	Peptide L6D/L12D/L17D/L20D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 9.69±0.38 µMol/L	1-h	Cervix	None
3769	22837667	2012	KWKSFLKTFKSlKKTVLHTlLKAISS	Peptide L12D/L20D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 3.14±0.06 µMol/L	1-h	Cervix	None
3770	22837667	2012	KWKSFlKTFKSlKKTVLHTlLKAISS	Peptide L6D/L12D/L20D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 7.80±0.26 µMol/L	1-h	Cervix	None
3767	22837667	2012	KWKSFLKTFKSLKKTVLHTlLKAISS	Peptide L20D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 2.33±0.06 µMol/L	1-h	Cervix	None
3768	22837667	2012	KWKSFlKTFKSlKKTVLHTLLKAISS	Peptide L6D/L12D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 3.01±0.08 µMol/L	1-h	Cervix	None
3766	22837667	2012	KWKSFLKTFKSlKKTVLHTLLKAISS	Peptide L12D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 2.63±0.07 µMol/L	1-h	Cervix	None
3765	22837667	2012	KWKSFlKTFKSLKKTVLHTLLKAISS	Peptide L6D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 2.23±0.10 µMol/L	1-h	Cervix	None
3764	22837667	2012	kWkSFLkTFkSLKkTVLHTLLkAISS	Peptide K1D/K3D/K7D /K10D/K14D/K22D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 18.07±0.48 µMol/L	1-h	Cervix	None
3762	22837667	2012	KWKSFLkTFkSLKkTVLHTLLkAISS	Peptide K7D /K10D/K14D/K22D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 4.79±0.23 µMol/L	1-h	Cervix	None
3763	22837667	2012	KWkSFLkTFkSLKkTVLHTLLkAISS	Peptide K3D/K7D /K10D/K14D/K22D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 20.41±0.64 µMol/L	1-h	Cervix	None
3761	22837667	2012	KWKSFLkTFKSLKkTVLHTLLKAISS	Peptide K7D /K14D/K22D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 4.45±0.19 µMol/L	1-h	Cervix	None
3760	22837667	2012	KWKSFLKTFKSLKkTVLHTLLkAISS	Peptide K14D/K22D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 1.40±0.09 µMol/L	1-h	Cervix	None
3759	22837667	2012	KWKSFLkTFKSLKkTVLHTLLKAISS	Peptide K7D /K14D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 2.06±0.01 µMol/L	1-h	Cervix	None
3758	22837667	2012	KWKSFLKTFKSLKKTVLHTLLkAISS	Peptide K22D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 1.39±0.02 µMol/L	1-h	Cervix	None
3757	22837667	2012	KWKSFLKTFKSLKkTVLHTLLKAISS	Peptide K14D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 1.52±0.05 µMol/L	1-h	Cervix	None
3756	22837667	2012	KWKSFLkTFKSLKKTVLHTLLKAISS	Peptide K7D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 1.29±0.03 µMol/L	1-h	Cervix	None
3755	22837667	2012	KWKSFLKTFKSLKKTVLHTLLKAISS	Peptide P	26	Linear	L	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 1.71±0.07 µMol/L	1-h	Cervix	None
3753	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀= 22.25 µM	72-h	Skin	None
3754	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀= 12.55 µM	72-h	Ovary	None
3751	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀= 22.51 µM	72-h	Stomach	None
3752	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀= 29.10 µM	72-h	Prostate	None
3750	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀= 14.8 µM	72-h	Colon	None
3748	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀= 21.48 µM	72-h	Renal	None
3749	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀= 14.53 µM	72-h	Lung	None
3746	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀= 27.39 µM	72-h	Skin	None
3747	22644847	2012	FLKWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀= 24.76 µM	72-h	Ovary	None
3745	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀= 47.69 µM	72-h	Prostate	None
3743	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀= 27.00 µM	72-h	Colon	None
3744	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀= 26.70 µM	72-h	Stomach	None
3741	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀= 41.21 µM	72-h	Renal	None
3742	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀= 25.20 µM	72-h	Lung	None
3740	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀= 14.58 µM	72-h	Ovary	None
3738	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀= 24.32 µM	72-h	Prostate	None
3739	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀= 13.16 µM	72-h	Skin	None
3736	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀= 14.80 µM	72-h	Colon	None
3737	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀= 13.77 µM	72-h	Stomach	None
3735	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀= 15.88 µM	72-h	Lung	None
3733	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀= 22.06 µM	72-h	Ovary	None
3734	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀= 22.59 µM	72-h	Renal	None
3732	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀= 13.97 µM	72-h	Skin	None
3730	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀= 24.31 µM	72-h	Stomach	None
3731	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀= 46.51 µM	72-h	Prostate	None
3728	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀= 20.36 µM	72-h	Lung	None
3729	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀= 24.63 µM	72-h	Colon	None
3726	22481251	2012	PLLQATLGGGS	P7	11	Linear	L	None	Free	Free	Antiproliferative and Antiangiogenic	NA	B16-F10	Skin Cancer	WST-1 assay	IC₅₀= 1 µM	48-h	Skin	None
3727	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Free	Free	Anticancer and Antimicrobial	Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀= 22.88 µM	72-h	Renal	None
3717	22100226	2012	GKWLSLLKHILK	HAL-2/11	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3718	24176852	2013	YGRKKRRQRRRREADFFWSLCTADMS	KilerFLIP	26	linear	L	None	Free	Free	NA	NA	Jurkat	Blood Cancer	Not Available	NA	NA	Blood	None
3716	22100226	2012	GKWMTLLKHILK	HAL-2/13	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3714	22100226	2012	GKFMSLLKHILK	HAL-2/24	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3715	22100226	2012	GKWMSFLKHILK	HAL-2/6	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3713	22100226	2012	GKWMSLWKHILK	HAL-2/20	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3711	22100226	2012	GKWMSLLKHIWK	HAL-2/18	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3712	22100226	2012	GKWMSLLKHWLK	HAL-2/19	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3709	22100226	2012	GKWKSLLKHILK	HAL-2/1	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Blood	None
3710	22100226	2012	GKWMSLLKHILK	HAL-2/8	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3708	22100226	2012	GKWMKLLKHILK	HAL-2/2	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Blood	None
3706	22100226	2012	gkwmsllkhilk	HAL-2/22	12	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3707	22100226	2012	GKWMSLLKKILK	HAL-2/4	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3704	22100226	2012	GMWSKLLGHLLR	HAL-1/15	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Blood	None
3705	22100226	2012	GKWMSLLKHILK	HAL-2	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 34 µM	48-h	Blood	None
3703	22100226	2012	GMWSKILGHLIR	HAL-1/29	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3701	22100226	2012	GKWKKILGHLIR	HAL-1/19	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3702	22100226	2012	GKWKKILGKLIR	HAL-1/21	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3700	22100226	2012	GKWSKILGKLIR	HAL-1/20	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Blood	None
3698	22100226	2012	KMWSKILGHLIR	HAL-1/17	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3699	22100226	2012	GMWKKILGKLIR	HAL-1/10	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3696	22100226	2012	GMWKKILGHLIR	HAL-1/5	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Blood	None
3697	22100226	2012	GKWSKILGHLIR	HAL-1/12	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Blood	None
3695	22100226	2012	GMWSKILKHLIR	HAL-1/18	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3693	22100226	2012	GMWSKILGHLKR	HAL-1/4	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3694	22100226	2012	GMWSKILGKLIR	HAL-1/9	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 30±10 µM	48-h	Blood	None
3692	22100226	2012	GMWSKILGHLIK	HAL-1/6	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3691	22100226	2012	gmwskilghlir	HAL-1/22	12	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3689	22100226	2012	GKWLSLLKHILK	HAL-2/11	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 40 µM	48-h	Colon	None
3690	22100226	2012	GMWSKILGHLIR	HAL-1	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 49±9 µM	48-h	Blood	None
3688	22100226	2012	GKWMTLLKHILK	HAL-2/13	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 60 µM	48-h	Colon	None
3687	22100226	2012	GKWMSFLKHILK	HAL-2/6	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3686	22100226	2012	GKFMSLLKHILK	HAL-2/24	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3685	22100226	2012	GKWMSLWKHILK	HAL-2/20	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3684	22100226	2012	GKWMSLLKHWLK	HAL-2/19	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3683	22100226	2012	GKWMSLLKHIWK	HAL-2/18	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3682	22100226	2012	GKWMSLLKHILK	HAL-2/8	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3681	22100226	2012	GKWKSLLKHILK	HAL-2/1	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3680	22100226	2012	GKWMKLLKHILK	HAL-2/2	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 35±5 µM	48-h	Colon	None
3679	22100226	2012	GKWMSLLKKILK	HAL-2/4	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 38±6 µM	48-h	Colon	None
3678	22100226	2012	gkwmsllkhilk	HAL-2/22	12	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3677	22100226	2012	GKWMSLLKHILK	HAL-2	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 35±3 µM	48-h	Colon	None
3676	22100226	2012	GMWSKLLGHLLR	HAL-1/15	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3675	22100226	2012	GMWSKILGHLIR	HAL-1/29	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3674	22100226	2012	GKWKKILGKLIR	HAL-1/21	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3673	22100226	2012	GKWKKILGHLIR	HAL-1/19	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3672	22100226	2012	GKWSKILGKLIR	HAL-1/20	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3671	22100226	2012	GMWKKILGKLIR	HAL-1/10	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 60 µM	48-h	Colon	None
3666	22100226	2012	GMWSKILGKLIR	HAL-1/9	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 50 µM	48-h	Colon	None
3667	22100226	2012	GMWSKILKHLIR	HAL-1/18	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 18±2 µM	48-h	Colon	None
3668	22100226	2012	GMWKKILGHLIR	HAL-1/5	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 44±5 µM	48-h	Colon	None
3669	22100226	2012	GKWSKILGHLIR	HAL-1/12	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3670	22100226	2012	KMWSKILGHLIR	HAL-1/17	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3661	22100226	2012	GKWLSLLKHILK	HAL-2/11	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 14±3 µM	48-h	Cervix	None
3662	22100226	2012	GMWSKILGHLIR	HAL-1	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 44±8 µM	48-h	Colon	None
3663	22100226	2012	gmwskilghlir	HAL-1/22	12	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3664	22100226	2012	GMWSKILGHLIK	HAL-1/6	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3665	22100226	2012	GMWSKILGHLKR	HAL-1/4	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3656	22100226	2012	GKWMSLLKHWLK	HAL-2/19	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 16±4 µM	48-h	Cervix	None
3657	22100226	2012	GKWMSLWKHILK	HAL-2/20	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 30±5 µM	48-h	Cervix	None
3658	22100226	2012	GKFMSLLKHILK	HAL-2/24	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 34 µM	48-h	Cervix	None
3659	22100226	2012	GKWMSFLKHILK	HAL-2/6	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 23±3 µM	48-h	Cervix	None
3660	22100226	2012	GKWMTLLKHILK	HAL-2/13	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 13±3 µM	48-h	Cervix	None
3652	22100226	2012	GKWMKLLKHILK	HAL-2/2	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 6±1 µM	48-h	Cervix	None
3653	22100226	2012	GKWKSLLKHILK	HAL-2/1	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 14±2 µM	48-h	Cervix	None
3654	22100226	2012	GKWMSLLKHILK	HAL-2/8	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 15±3 µM	48-h	Cervix	None
3655	22100226	2012	GKWMSLLKHIWK	HAL-2/18	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 14±2 µM	48-h	Cervix	None
3647	22100226	2012	GMWSKILGHLIR	HAL-1/29	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Cervix	None
3648	22100226	2012	GMWSKLLGHLLR	HAL-1/15	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 14±2 µM	48-h	Cervix	None
3649	22100226	2012	GKWMSLLKHILK	HAL-2	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 12±1 µM	48-h	Cervix	None
3650	22100226	2012	gkwmsllkhilk	HAL-2/22	12	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 12 µM	48-h	Cervix	None
3651	22100226	2012	GKWMSLLKKILK	HAL-2/4	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Cervix	None
3645	22100226	2012	GKWKKILGHLIR	HAL-1/19	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Cervix	None
3646	22100226	2012	GKWKKILGKLIR	HAL-1/21	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 30±3 µM	48-h	Cervix	None
3644	22100226	2012	GKWSKILGKLIR	HAL-1/20	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 22±3 µM	48-h	Cervix	None
3643	22100226	2012	GMWKKILGKLIR	HAL-1/10	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 13±2 µM	48-h	Cervix	None
3642	22100226	2012	KMWSKILGHLIR	HAL-1/17	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 35±3 µM	48-h	Cervix	None
3640	22100226	2012	GMWKKILGHLIR	HAL-1/5	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 9±1 µM	48-h	Cervix	None
3641	22100226	2012	GKWSKILGHLIR	HAL-1/12	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 43±14 µM	48-h	Cervix	None
3639	22100226	2012	GMWSKILKHLIR	HAL-1/18	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 4±2 µM	48-h	Cervix	None
3638	22100226	2012	GMWSKILGKLIR	HAL-1/9	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 9±1 µM	48-h	Cervix	None
3637	22100226	2012	GMWSKILGHLKR	HAL-1/4	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Cervix	None
3636	22100226	2012	GMWSKILGHLIK	HAL-1/6	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 15±1 µM	48-h	Cervix	None
3634	22100226	2012	GMWSKILGHLIR	HAL-1	12	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 11±2 µM	48-h	Cervix	None
3635	22100226	2012	gmwskilghlir	HAL-1/22	12	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Halictines and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 15±3 µM	48-h	Cervix	None
3633	22100226	2012	GFGMA-(AC6C)-KLLKKVL	MAC1/26	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 9±2 µM	48-h	Blood	None
3631	22100226	2012	GFGMALKL-(AC6C)-KKVL	MAC1/24	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 11 µM	48-h	Blood	None
3632	22100226	2012	GFGMALK-(AC6C)-LKKVL	MAC1/25	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 12±2 µM	48-h	Blood	None
3630	22100226	2012	GFGMALRLLRRVL	MAC1/21	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 22±4 µM	48-h	Blood	None
3629	22100226	2012	GFGMALOLLOOVL	MAC1/20	13	Linear	L	O = Ornithine	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 25±3 µM	48-h	Blood	None
3628	22100226	2012	GFGMALKLLKKVL	MAC1/19	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 43±11 µM	48-h	Blood	None
3626	22100226	2012	GFKMALKLLKKVL	MAC1/10	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 16 µM	48-h	Blood	None
3627	22100226	2012	GFGMALKLLKKVL	MAC1/16	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 70 µM	48-h	Blood	None
3625	22100226	2012	GFKMALKLLKKVL	MAC1/9	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 14±4 µM	48-h	Blood	None
3624	22100226	2012	GFGMALKLLKKVL	MAC1/6	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 15 µM	48-h	Blood	None
3622	22100226	2012	LFGMALKLLKKVL	MAC1/3	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 22 µM	48-h	Blood	None
3623	22100226	2012	GFGMALKLLKKVL	MAC1/4	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 29 µM	48-h	Blood	None
3621	22100226	2012	AFGMALKLLKKVL	MAC1/2	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 17 µM	48-h	Blood	None
3620	22100226	2012	gfgmalkllkkvl	MAC1/1	13	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 11 µM	48-h	Blood	None
3619	22100226	2012	GTGLPMSERRKIMLMMR	MAC2	17	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 32 µM	48-h	Blood	None
3616	22100226	2012	GFGMALK-(AC6C)-LKKVL	MAC1/25	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 14±1 µM	48-h	Colon	None
3617	22100226	2012	GFGMA-(AC6C)-KLLKKVL	MAC1/26	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 18±1 µM	48-h	Colon	None
3618	22100226	2012	GFGMALKLLKKVL	MAC1	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 12±6 µM	48-h	Blood	None
3615	22100226	2012	GFGMALKL-(AC6C)-KKVL	MAC1/24	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 16±1 µM	48-h	Colon	None
3613	22100226	2012	GFGMALOLLOOVL	MAC1/20	13	Linear	L	O = Ornithine	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 35±4 µM	48-h	Colon	None
3614	22100226	2012	GFGMALRLLRRVL	MAC1/21	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 17±2 µM	48-h	Colon	None
3612	22100226	2012	GFGMALKLLKKVL	MAC1/19	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 68±2 µM	48-h	Colon	None
3611	22100226	2012	GFGMALKLLKKVL	MAC1/16	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3610	22100226	2012	GFKMALKLLKKVL	MAC1/10	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3609	22100226	2012	GFKMALKLLKKVL	MAC1/9	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 13±3 µM	48-h	Colon	None
3607	22100226	2012	GFGMALKLLKKVL	MAC1/4	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 49±9 µM	48-h	Colon	None
3608	22100226	2012	GFGMALKLLKKVL	MAC1/6	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 29±3 µM	48-h	Colon	None
3606	22100226	2012	LFGMALKLLKKVL	MAC1/3	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 11±1 µM	48-h	Colon	None
3604	22100226	2012	gfgmalkllkkvl	MAC1/1	13	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 19±2 µM	48-h	Colon	None
3605	22100226	2012	AFGMALKLLKKVL	MAC1/2	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 16 µM	48-h	Colon	None
3603	22100226	2012	GTGLPMSERRKIMLMMR	MAC2	17	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3601	22100226	2012	GFGMA-(AC6C)-KLLKKVL	MAC1/26	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 8±2 µM	48-h	Cervix	None
3602	22100226	2012	GFGMALKLLKKVL	MAC1	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 23±4 µM	48-h	Colon	None
3599	22100226	2012	GFGMALKL-(AC6C)-KKVL	MAC1/24	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 8±2 µM	48-h	Cervix	None
3600	22100226	2012	GFGMALK-(AC6C)-LKKVL	MAC1/25	13	Linear	L	AC6C = cyclohexyl-1-carboxylic acid	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 7±1 µM	48-h	Cervix	None
3597	22100226	2012	GFGMALOLLOOVL	MAC1/20	13	Linear	L	O = Ornithine	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 10±1 µM	48-h	Cervix	None
3598	22100226	2012	GFGMALRLLRRVL	MAC1/21	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 9±3 µM	48-h	Cervix	None
3595	22100226	2012	GFGMALKLLKKVL	MAC1/16	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 32±2 µM	48-h	Cervix	None
3596	22100226	2012	GFGMALKLLKKVL	MAC1/19	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 21±4 µM	48-h	Cervix	None
3594	22100226	2012	GFKMALKLLKKVL	MAC1/10	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 15±6 µM	48-h	Cervix	None
3592	22100226	2012	GFGMALKLLKKVL	MAC1/6	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 8±2 µM	48-h	Cervix	None
3593	22100226	2012	GFKMALKLLKKVL	MAC1/9	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 8±1 µM	48-h	Cervix	None
3591	22100226	2012	GFGMALKLLKKVL	MAC1/4	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 15±5 µM	48-h	Cervix	None
3589	22100226	2012	AFGMALKLLKKVL	MAC1/2	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 16±3 µM	48-h	Cervix	None
3590	22100226	2012	LFGMALKLLKKVL	MAC1/3	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 9±2 µM	48-h	Cervix	None
3588	22100226	2012	gfgmalkllkkvl	MAC1/1	13	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 12±4 µM	48-h	Cervix	None
3587	22100226	2012	GTGLPMSERRKIMLMMR	MAC2	17	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Cervix	None
3586	22100226	2012	GFGMALKLLKKVL	MAC1	13	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Macropins and their analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 10±4 µM	48-h	Cervix	None
3569	22100226	2012	VNWKKILGKIIKVVK	LL-III/37	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀= 4±1 µM	48-h	Blood	None
3567	22100226	2012	NKWKKILGKIIKVVK	LL-III/34	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 5±3 µM	48-h	Blood	None
3568	22100226	2012	VNWKKILAKIIKVVK	LL-III/36	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3566	22100226	2012	VNWKKVLGKVVKVVK	LL-III/27	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 18 µM	48-h	Blood	None
3565	22100226	2012	VYWKKILGKIIKVVK	LL-III/26	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 6 µM	48-h	Blood	None
3563	22100226	2012	VNWOOILGOIIOVVO	LL-III/24	15	Linear	L	O = Ornithine	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 5±2 µM	48-h	Blood	None
3564	22100226	2012	vnwkkllgkllkvvk	LL-III/25	15	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 4 µM	48-h	Blood	None
3562	22100226	2012	VNWKKLLGKLLKVVK	LL-III/23	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 6 µM	48-h	Blood	None
3561	22100226	2012	KNWKK-Aib-LKK-Aib-IK-Aib-VK	LL-III/22	15	Linear	L	Aib = 1-amino-isobutyric acid	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 25±4 µM	48-h	Blood	None
3560	22100226	2012	VNWKK-Aib-LGK-Aib-IK-Aib-VK	LL-III/19	15	Linear	L	Aib = 1-amino-isobutyric acid	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 8±2 µM	48-h	Blood	None
3559	22100226	2012	KNWKKILKKIIKVVK	LL-III/18	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 7±2 µM	48-h	Blood	None
3558	22100226	2012	VNWRRILGRIIRVVR	LL-III/17	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3557	22100226	2012	VN-Nal-KKLLGKLLKVVK	LL-III/16	15	Linear	L	Nal = 3-(1-naphthyl)alanine	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3556	22100226	2012	VNFKKLLGKLLKVVK	LL-III/15	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 9±3 µM	48-h	Blood	None
3555	22100226	2012	vnwkkilgkiikvvk	LL-III/12	15	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 5±2 µM	48-h	Blood	None
3554	22100226	2012	VNWKKIILGKIIKVVK	LL-III/11	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 4±1 µM	48-h	Blood	None
3552	22100226	2012	VNWKKILGKIIKVVK	LL-III/9	15	Linear	L	None	Methoxylation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3553	22100226	2012	KNWKKILGKIIKVVK	LL-III/10	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 9 µM	48-h	Blood	None
3551	22100226	2012	VNWKKILGKIIKVVK	LL-III/8	15	Linear	L	None	Free	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 9 µM	48-h	Blood	None
3549	22100226	2012	VNWKKILGKIKKVVK	LL-III/4	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 18 µM	48-h	Blood	None
3550	22100226	2012	VNWKKILPKIIKVVK	LL-III/6	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 6±3 µM	48-h	Blood	None
3548	22100226	2012	VNWKKILKKIIKVVK	LL-III/3	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	Not tested	48-h	Blood	None
3547	22100226	2012	NVWKKILGKIIKVVK	LL-III/2	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 7±2 µM	48-h	Blood	None
3545	22100226	2012	VNWKKILGKIIKVVK	LL-III	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 5±3 µM	48-h	Blood	None
3546	22100226	2012	VNWKKILAKIIKVVK	LL-III/1	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀ = 3±1 µM	48-h	Blood	None
3544	22100226	2012	VNWKKILGKIIKVVK	LL-III/37	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 13 µM	48-h	Colon	None
3542	22100226	2012	NKWKKILGKIIKVVK	LL-III/34	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 37 µM	48-h	Colon	None
3543	22100226	2012	VNWKKILAKIIKVVK	LL-III/36	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3541	22100226	2012	VNWKKVLGKVVKVVK	LL-III/27	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3539	22100226	2012	vnwkkllgkllkvvk	LL-III/25	15	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 20 µM	48-h	Colon	None
3540	22100226	2012	VYWKKILGKIIKVVK	LL-III/26	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 30 µM	48-h	Colon	None
3538	22100226	2012	VNWOOILGOIIOVVO	LL-III/24	15	Linear	L	O = Ornithine	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 20 µM	48-h	Colon	None
3537	22100226	2012	VNWKKLLGKLLKVVK	LL-III/23	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 15 µM	48-h	Colon	None
3535	22100226	2012	VNWKK-Aib-LGK-Aib-IK-Aib-VK	LL-III/19	15	Linear	L	Aib = 1-amino-isobutyric acid	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 28 µM	48-h	Colon	None
3536	22100226	2012	KNWKK-Aib-LKK-Aib-IK-Aib-VK	LL-III/22	15	Linear	L	Aib = 1-amino-isobutyric acid	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 100 µM	48-h	Colon	None
3534	22100226	2012	KNWKKILKKIIKVVK	LL-III/18	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3533	22100226	2012	VNWRRILGRIIRVVR	LL-III/17	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3532	22100226	2012	VN-Nal-KKLLGKLLKVVK	LL-III/16	15	Linear	L	Nal = 3-(1-naphthyl)alanine	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3531	22100226	2012	VNFKKLLGKLLKVVK	LL-III/15	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 42 µM	48-h	Colon	None
3530	22100226	2012	vnwkkilgkiikvvk	LL-III/12	15	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 20 µM	48-h	Colon	None
3528	22100226	2012	KNWKKILGKIIKVVK	LL-III/10	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3529	22100226	2012	VNWKKIILGKIIKVVK	LL-III/11	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 48 µM	48-h	Colon	None
3527	22100226	2012	VNWKKILGKIIKVVK	LL-III/9	15	Linear	L	None	Methoxylation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 25± 5 µM	48-h	Colon	None
3525	22100226	2012	VNWKKILPKIIKVVK	LL-III/6	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3526	22100226	2012	VNWKKILGKIIKVVK	LL-III/8	15	Linear	L	None	Free	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	Not tested	48-h	Colon	None
3524	22100226	2012	VNWKKILGKIKKVVK	LL-III/4	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3522	22100226	2012	NVWKKILGKIIKVVK	LL-III/2	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 11 µM	48-h	Colon	None
3523	22100226	2012	VNWKKILKKIIKVVK	LL-III/3	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Colon	None
3521	22100226	2012	VNWKKILAKIIKVVK	LL-III/1	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 12± 3 µM	48-h	Colon	None
3519	22100226	2012	VNWKKILGKIIKVVK	LL-III/37	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 5±1 µM	48-h	Colon	None
3520	22100226	2012	VNWKKILGKIIKVVK	LL-III	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	SW	Colon Cancer	MTT/MTS assay	IC₅₀ = 18±4 µM	48-h	Colon	None
3518	22100226	2012	VNWKKILAKIIKVVK	LL-III/36	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 8 µM	48-h	Cervix	None
3516	22100226	2012	VNWKKVLGKVVKVVK	LL-III/27	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 13±2 µM	48-h	Cervix	None
3517	22100226	2012	NKWKKILGKIIKVVK	LL-III/34	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 5±2 µM	48-h	Cervix	None
3515	22100226	2012	VYWKKILGKIIKVVK	LL-III/26	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 5±1 µM	48-h	Cervix	None
3513	22100226	2012	VNWOOILGOIIOVVO	LL-III/24	15	Linear	L	O = Ornithine	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 3±1 µM	48-h	Cervix	None
3514	22100226	2012	vnwkkllgkllkvvk	LL-III/25	15	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 4±2 µM	48-h	Cervix	None
3512	22100226	2012	VNWKKLLGKLLKVVK	LL-III/23	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 4 µM	48-h	Cervix	None
3511	22100226	2012	KNWKK-Aib-LKK-Aib-IK-Aib-VK	LL-III/22	15	Linear	L	Aib = 1-amino-isobutyric acid	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 11±7 µM	48-h	Cervix	None
3509	22100226	2012	KNWKKILKKIIKVVK	LL-III/18	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 3 µM	48-h	Cervix	None
3510	22100226	2012	VNWKK-Aib-LGK-Aib-IK-Aib-VK	LL-III/19	15	Linear	L	Aib = 1-amino-isobutyric acid	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 3±1 µM	48-h	Cervix	None
3508	22100226	2012	VNWRRILGRIIRVVR	LL-III/17	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 9 µM	48-h	Cervix	None
3505	22100226	2012	vnwkkilgkiikvvk	LL-III/12	15	Linear	D	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 6±2 µM	48-h	Cervix	None
3506	22100226	2012	VNFKKLLGKLLKVVK	LL-III/15	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 7±1 µM	48-h	Cervix	None
3507	22100226	2012	VN-Nal-KKLLGKLLKVVK	LL-III/16	15	Linear	L	Nal = 3-(1-naphthyl)alanine	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 6±1 µM	48-h	Cervix	None
3502	22100226	2012	VNWKKILGKIIKVVK	LL-III/9	15	Linear	L	None	Methoxylation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 3±1 µM	48-h	Cervix	None
3503	22100226	2012	KNWKKILGKIIKVVK	LL-III/10	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 9±4 µM	48-h	Cervix	None
3504	22100226	2012	VNWKKIILGKIIKVVK	LL-III/11	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 8±1 µM	48-h	Cervix	None
3499	22100226	2012	VNWKKILGKIKKVVK	LL-III/4	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 7±1 µM	48-h	Cervix	None
3500	22100226	2012	VNWKKILPKIIKVVK	LL-III/6	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ > 40 µM	48-h	Cervix	None
3501	22100226	2012	VNWKKILGKIIKVVK	LL-III/8	15	Linear	L	None	Free	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 12±1 µM	48-h	Cervix	None
3497	22100226	2012	NVWKKILGKIIKVVK	LL-III/2	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	Not tested	48-h	Cervix	None
3498	22100226	2012	VNWKKILKKIIKVVK	LL-III/3	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	Not tested	48-h	Cervix	None
3495	22100226	2012	VNWKKILGKIIKVVK	LL-III	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 4±1 µM	48-h	Cervix	None
3496	22100226	2012	VNWKKILAKIIKVVK	LL-III/1	15	Linear	L	None	Amidation	Free	Antimicrobial and Antifungal	Lasioglossin III and its analogs	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀ = 3±1 µM	48-h	Cervix	None
3468	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HTB-9	Bladder Cancer	MTT/MTS assay	~30% cytotoxicity at 1 µM	72-h	Bladder	WO_2012042540_A2
3469	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HTB-9	Bladder Cancer	MTT/MTS assay	>40% cytotoxicity at 10 µM	72-h	Bladder	WO_2012042540_A2
3466	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HTB-9	Bladder Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	48-h	Bladder	WO_2012042540_A2
3467	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HTB-9	Bladder Cancer	MTT/MTS assay	20% cytotoxicity at 10 µM	48-h	Bladder	WO_2012042540_A2
3464	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HTB-9	Bladder Cancer	MTT/MTS assay	40% cytotoxicity at 1 µM	24-h	Bladder	WO_2012042540_A2
3465	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HTB-9	Bladder Cancer	MTT/MTS assay	~50% cytotoxicity at 10 µM	24-h	Bladder	WO_2012042540_A2
3462	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	72-h	Bladder	WO_2012042540_A2
3463	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<5% cytotoxicity at 10 µM	72-h	Bladder	WO_2012042540_A2
3460	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	48-h	Bladder	WO2012042540A2
3461	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<3% cytotoxicity at 10 µM	48-h	Bladder	WO_2012042540_A2
3458	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<15% cytotoxicity at 1 µM	24-h	Bladder	WO_2012042540_A2
3459	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	~15% cytotoxicity at 10 µM	24-h	Bladder	WO_2012042540_A2
3456	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	72-h	Bladder	WO_2012042540_A2
3457	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	~15% cytotoxicity at 10 µM	72-h	Bladder	WO_2012042540_A2
3454	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	48-h	Bladder	WO_2012042540_A2
3455	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<3% cytotoxicity at 10 µM	48-h	Bladder	WO_2012042540_A2
3452	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	20% cytotoxicity at 1 µM	24-h	Bladder	WO2012042540A2
3453	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	~10% cytotoxicity at 10 µM	24-h	Bladder	WO_2012042540_A2
3450	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	CaSki	Cervical Cancer	MTT/MTS assay	~20% cytotoxicity at 1 µM	72-h	Cervix	WO_2012042540_A2
3451	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	CaSki	Cervical Cancer	MTT/MTS assay	~45% cytotoxicity at 10 µM	72-h	Cervix	WO_2012042540_A2
3449	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	CaSki	Cervical Cancer	MTT/MTS assay	~55% cytotoxicity at 10 µM	48-h	Cervix	WO_2012042540_A2
3447	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	CaSki	Cervical Cancer	MTT/MTS assay	~40% cytotoxicity at 10 µM	24-h	Cervix	WO_2012042540_A2
3448	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	CaSki	Cervical Cancer	MTT/MTS assay	~20% cytotoxicity at 1 µM	48-h	Cervix	WO_2012042540_A2
3445	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	>20% cytotoxicity at 10 µM	72-h	Cervix	WO_2012042540_A2
3446	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	CaSki	Cervical Cancer	MTT/MTS assay	~20% cytotoxicity at 1 µM	24-h	Cervix	WO_2012042540_A2
3443	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	>20% cytotoxicity at 10 µM	48-h	Cervix	WO_2012042540_A2
3444	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	~15% cytotoxicity at 1 µM	72-h	Cervix	WO2012042540A2
3441	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	~15% cytotoxicity at 10 µM	24-h	Cervix	WO_2012042540_A2
3442	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	<3% cytotoxicity at 1 µM	48-h	Cervix	WO_2012042540_A2
3439	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	20% cytotoxicity at 10 µM	72-h	Cervix	WO_2012042540_A2
3440	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	~5% cytotoxicity at 1 µM	24-h	Cervix	WO_2012042540_A2
3437	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	<10% cytotoxicity at 10 µM	48-h	Cervix	WO_2012042540_A2
3438	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	72-h	Cervix	WO_2012042540_A2
3435	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	~5% cytotoxicity at 10 µM	24-h	Cervix	WO_2012042540_A2
3436	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	~10% cytotoxicity at 1 µM	48-h	Cervix	WO2012042540A2
3433	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	SiHa	Cervical Cancer	MTT/MTS assay	~45% cytotoxicity at 10 µM	72-h	Cervix	WO_2012042540_A2
3434	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	~15% cytotoxicity at 1 µM	24-h	Cervix	WO_2012042540_A2
3432	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	SiHa	Cervical Cancer	MTT/MTS assay	~20% cytotoxicity at 1 µM	72-h	Cervix	WO_2012042540_A2
3431	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	SiHa	Cervical Cancer	MTT/MTS assay	~50% cytotoxicity at 10 µM	48-h	Cervix	WO_2012042540_A2
3430	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	SiHa	Cervical Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	48-h	Cervix	WO_2012042540_A2
3429	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	SiHa	Cervical Cancer	MTT/MTS assay	>40% cytotoxicity at 10 µM	24-h	Cervix	WO_2012042540_A2
3428	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	SiHa	Cervical Cancer	MTT/MTS assay	>20% cytotoxicity at 1 µM	24-h	Cervix	WO2012042540A2
3427	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	~40% cytotoxicity at 10 µM	72-h	Cervix	WO_2012042540_A2
3426	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	~20% cytotoxicity at 1 µM	72-h	Cervix	WO_2012042540_A2
3425	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	>20% cytotoxicity at 10 µM	48-h	Cervix	WO_2012042540_A2
3424	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	<3% cytotoxicity at 1 µM	48-h	Cervix	WO_2012042540_A2
3423	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	>10% cytotoxicity at 10 µM	24-h	Cervix	WO_2012042540_A2
3422	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	5% cytotoxicity at 1 µM	24-h	Cervix	WO_2012042540_A2
3421	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	20% cytotoxicity at 10 µM	72-h	Cervix	WO_2012042540_A2
3420	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	72-h	Cervix	WO2012042540A2
3419	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	<10% cytotoxicity at 10 µM	48-h	Cervix	WO_2012042540_A2
3418	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	10% cytotoxicity at 1 µM	48-h	Cervix	WO_2012042540_A2
3417	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	5% cytotoxicity at 10 µM	24-h	Cervix	WO_2012042540_A2
3416	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	~15% cytotoxicity at 1 µM	24-h	Cervix	WO_2012042540_A2
3415	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HCT-116	Colon Cancer	MTT/MTS assay	~40% cytotoxicity at 10 µM	72-h	Colon	WO_2012042540_A2
3414	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HCT-116	Colon Cancer	MTT/MTS assay	>30% cytotoxicity at 1 µM	72-h	Colon	WO_2012042540_A2
3413	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HCT-116	Colon Cancer	MTT/MTS assay	>20% cytotoxicity at 10 µM	48-h	Colon	WO_2012042540_A2
3412	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HCT-116	Colon Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	48-h	Colon	WO2012042540A2
3411	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HCT-116	Colon Cancer	MTT/MTS assay	50% cytotoxicity at 10 µM	24-h	Colon	WO_2012042540_A2
3410	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HCT-116	Colon Cancer	MTT/MTS assay	>40% cytotoxicity at 1 µM	24-h	Colon	WO_2012042540_A2
3409	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 10 µM	72-h	Colon	WO_2012042540_A2
3408	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	72-h	Colon	WO_2012042540_A2
3407	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 10 µM	48-h	Colon	WO_2012042540_A2
3406	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	~5% cytotoxicity at 1 µM	48-h	Colon	WO_2012042540_A2
3405	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	15% cytotoxicity at 10 µM	24-h	Colon	WO_2012042540_A2
3404	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<15% cytotoxicity at 1 µM	24-h	Colon	WO2012042540A2
3403	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	15% cytotoxicity at 10 µM	72-h	Colon	WO_2012042540_A2
3402	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	72-h	Colon	WO_2012042540_A2
3399	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	10% cytotoxicity at 10 µM	24-h	Colon	WO_2012042540_A2
3400	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	48-h	Colon	WO_2012042540_A2
3401	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<3% cytotoxicity at 10 µM	48-h	Colon	WO_2012042540_A2
3396	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	UM-UC-3	Bladder Cancer	MTT/MTS assay	>40% cytotoxicity at 1 µM	72-h	Bladder	WO2012042540A2
3397	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	UM-UC-3	Bladder Cancer	MTT/MTS assay	~50% cytotoxicity at 10 µM	72-h	Bladder	WO_2012042540_A2
3398	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	20% cytotoxicity at 1 µM	24-h	Colon	WO_2012042540_A2
3395	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	UM-UC-3	Bladder Cancer	MTT/MTS assay	~50% cytotoxicity at 10 µM	48-h	Bladder	WO_2012042540_A2
3394	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	UM-UC-3	Bladder Cancer	MTT/MTS assay	<30% cytotoxicity at 1 µM	48-h	Bladder	WO_2012042540_A2
3393	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	UM-UC-3	Bladder Cancer	MTT/MTS assay	<30% cytotoxicity at 10 µM	24-h	Bladder	WO_2012042540_A2
3392	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	UM-UC-3	Bladder Cancer	MTT/MTS assay	~30% cytotoxicity at 1 µM	24-h	Bladder	WO_2012042540_A2
3391	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	<45% cytotoxicity at 10 µM	72-h	Bladder	WO_2012042540_A2
3390	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	~45% cytotoxicity at 1 µM	72-h	Bladder	WO_2012042540_A2
3389	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	>25% cytotoxicity at 10 µM	48-h	Bladder	WO_2012042540_A2
3388	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	~25% cytotoxicity at 1 µM	48-h	Bladder	WO2012042540A2
3387	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	~25% cytotoxicity at 10 µM	24-h	Bladder	WO_2012042540_A2
3386	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	~25% cytotoxicity at 1 µM	24-h	Bladder	WO_2012042540_A2
3385	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	<45% cytotoxicity at 10 µM	72-h	Bladder	WO_2012042540_A2
3384	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	~45% cytotoxicity at 1 µM	72-h	Bladder	WO_2012042540_A2
3383	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	<25% cytotoxicity at 10 µM	48-h	Bladder	WO_2012042540_A2
3382	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	~25% cytotoxicity at 1 µM	48-h	Bladder	WO_2012042540_A2
3381	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	<10% cytotoxicity at 10 µM	24-h	Bladder	WO_2012042540_A2
3380	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	10% cytotoxicity at 1 µM	24-h	Bladder	WO2012042540A2
3379	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	COLO-205	Colon Cancer	MTT/MTS assay	~20% cytotoxicity at 10 µM	72-h	Colon	WO_2012042540_A2
3378	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	72-h	Colon	WO_2012042540_A2
3377	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	COLO-205	Colon Cancer	MTT/MTS assay	~35% cytotoxicity at 10 µM	48-h	Colon	WO_2012042540_A2
3376	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	COLO-205	Colon Cancer	MTT/MTS assay	>20% cytotoxicity at 1 µM	48-h	Colon	WO_2012042540_A2
3375	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 10 µM	24-h	Colon	WO_2012042540_A2
3374	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	24-h	Colon	WO_2012042540_A2
3373	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 10 µM	72-h	Colon	WO_2012042540_A2
3372	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	>10% cytotoxicity at 1 µM	72-h	Colon	WO2012042540A2
3371	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	>10% cytotoxicity at 10 µM	48-h	Colon	WO_2012042540_A2
3370	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	10% cytotoxicity at 1 µM	48-h	Colon	WO_2012042540_A2
3369	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	~10% cytotoxicity at 10 µM	24-h	Colon	WO_2012042540_A2
3368	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	24-h	Colon	WO_2012042540_A2
3367	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 10 µM	72-h	Colon	WO_2012042540_A2
3366	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	72-h	Colon	WO_2012042540_A2
3365	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	>20% cytotoxicity at 10 µM	48-h	Colon	WO_2012042540_A2
3362	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	24-h	Colon	WO_2012042540_A2
3363	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	<20% cytotoxicity at 10 µM	24-h	Colon	WO_2012042540_A2
3364	None	2012	NHFTLKCPKTALTEPPTLAY	TG20	20	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	~15% cytotoxicity at 1 µM	48-h	Colon	WO2012042540A2
3338	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =2.1 ± 0.1 µM	2-h	Skin	None
3339	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =1.8 ± 0.1 µM	4-h	Skin	None
3340	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =1.4 ± 0.1 µM	24-h	Skin	None
3341	23533710	2013	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Amidation	Free	Antihypertensive and Antimicrobial and Antiviral and Antioxidant	Bovine milk	AZ-97	Colon Cancer	MTT/MTS assay	Inhibition at 0.1g/l	NA	Colon	None
3342	23533710	2013	YPFPG	β-Casomorphins 5 f(60_64)	4	Linear	L	None	Amidation	Free	Immunomodulant, Antihypertensive, Antimicrobial,Antiviral, and Antioxidant	Bovine milk	AZ-97	Colon Cancer	MTT/MTS assay	Inhibition at 9-11g/l	NA	Colon	None
3343	23533710	2013	RYLGYL	αs1-casein f(90_95)	6	Linear	L	None	Amidation	Free	Immunomodulant, Antihypertensive, Antimicrobial,Antiviral, and Antioxidant	Bovine milk	AZ-97	Colon Cancer	MTT/MTS assay	Inhibition at 12-15g/l	NA	Colon	None
3344	23533710	2013	PPPEE	Caseinphosphopeptides	5	Linear	L	None	Amidation	Free	Immunomodulant, Antihypertensive, Antimicrobial,Antiviral, and Antioxidant	Bovine milk	AZ-97	Colon Cancer	MTT/MTS assay	Inhibition at 24-28g/l	NA	Colon	None
3345	22820149	2012	Structure Given	BAA-1	Not Available	Linear	L	None	Amidation	Free	Antimicrobial	Bovine lactoferrin (Lf-B)	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀ = 8.1 µg/ml	1-h	Blood	None
3346	22820149	2012	Structure Given	BAA-2	Not Available	Linear	L	None	Amidation	Free	Antimicrobial	Bovine lactoferrin (Lf-B)	Ramos	Lymphoma Cancer	MTT/MTS assay	IC₅₀ = 3.8 µg/ml	8-h	Blood	None
3329	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A-Δ	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =7.5 ± 0.4 µM	30-Min	Skin	None
3330	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A-Δ	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =13.8 ± 2.0 µM	2-h	Skin	None
3331	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A-Δ	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =9.3 ± 1.5 µM	4-h	Skin	None
3332	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A-Δ	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =13.1 ± 0.9 µM	24-h	Skin	None
3333	23893605	2013	KISKRILTGKK	NK11	11	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ >>100 µM	30-Min	Skin	None
3334	23893605	2013	KISKRILTGKK	NK11	11	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ >>100 µM	2-h	Skin	None
3335	23893605	2013	KISKRILTGKK	NK11	11	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ >>100 µM	4-h	Skin	None
3336	23893605	2013	KISKRILTGKK	NK11	11	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ >>100 µM	24-h	Skin	None
3337	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =3.2 ± 0.1 µM	30-Min	Skin	None
3328	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =12.3 ± 1.0 µM	24-h	Skin	None
3327	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =8.3 ± 0.5 µM	4-h	Skin	None
3326	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =12.3 ± 2.0 µM	2-h	Skin	None
3325	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =8.4 ± 0.2 µM	30-Min	Skin	None
3324	23893605	2013	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =37 ± 4.3 µM	24-h	Skin	None
3323	23893605	2013	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =12.1 ± 1.6 µM	4-h	Skin	None
3322	23893605	2013	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =13.0 ± 1.0 µM	2-h	Skin	None
3321	23893605	2013	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =10.6 ± 0.4 µM	30-Min	Skin	None
3320	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ = ~40 µM	24-h	Skin	None
3319	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ = ~50 µM	4-h	Skin	None
3318	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ = ~50 µM	2-h	Skin	None
3317	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ = ~70 µM	30-Min	Skin	None
3316	21453492, 23533710	2011	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Bovine lactoferrin (Lf-B)	Kelly	Brain Tumor	MTT/MTS assay	IC₅₀ =141 ± 3 µM	30-Min	Brain	None
3315	21453492, 23533710	2011	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Bovine lactoferrin (Lf-B)	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀ > 160 µM	30-Min	Breast	None
3313	21453492	2011	OOW-Dip-OOWWO	LTX-318	9	Linear	L	Dip = diphenylalanine, O=ornithine	Amidation	Free	Antimicrobial	Synthetic peptide	Kelly	Brain Tumor	MTT/MTS assay	IC₅₀ =78 ± 7 µM	30-Min	Brain	None
3314	21453492, 23533710	2011	FKCRRWQWRMKK	LfcinB	12	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Bovine lactoferrin (Lf-B)	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀ > 160 µM	30-Min	Colon	None
3312	21453492	2011	OOW-Dip-OOWWO	LTX-318	9	Linear	L	Dip = diphenylalanine, O=ornithine	Amidation	Free	Antimicrobial	Synthetic peptide	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀ =216 ± 36 µM	30-Min	Breast	None
3311	21453492	2011	OOW-Dip-OOWWO	LTX-318	9	Linear	L	Dip = diphenylalanine, O=ornithine	Amidation	Free	Antimicrobial	Synthetic peptide	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀ =248 ± 5 µM	30-Min	Colon	None
3309	21453492	2011	KKWWKKW-Dip-K	LTX-315	9	Linear	L	Dip = diphenylalanine	Amidation	Free	Antimicrobial	Synthetic peptide	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀ =31 ± 3 µM	30-Min	Breast	None
3310	21453492	2011	KKWWKKW-Dip-K	LTX-315	9	Linear	L	Dip = diphenylalanine	Amidation	Free	Antimicrobial	Synthetic peptide	Kelly	Brain Tumor	MTT/MTS assay	IC₅₀ =14 ± 1 µM	30-Min	Brain	None
3308	21453492	2011	KKWWKKW-Dip-K	LTX-315	9	Linear	L	Dip = diphenylalanine	Amidation	Free	Antimicrobial	Synthetic peptide	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀ =38 ± 3 µM	30-Min	Colon	None
3307	21453492	2011	WKKW-Dip-KKWK	LTX-302	9	Linear	L	Dip = diphenylalanine	Amidation	Free	Antimicrobial	Synthetic peptide	Kelly	Brain Tumor	MTT/MTS assay	IC₅₀ =28 ± 0 µM	30-Min	Brain	None
3306	21453492	2011	WKKW-Dip-KKWK	LTX-302	9	Linear	L	Dip = diphenylalanine	Amidation	Free	Antimicrobial	Synthetic peptide	MT-1	Breast Cancer	MTT/MTS assay	IC₅₀ =73 ± 2 µM	30-Min	Breast	None
3305	21453492	2011	WKKW-Dip-KKWK	LTX-302	9	Linear	L	Dip = diphenylalanine	Amidation	Free	Antimicrobial	Synthetic peptide	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀ =75 ± 5 µM	30-Min	Colon	None
3267	22934601	2012	FLGALFKALSHLL	PTP-7b	13	Linear	L	None	Free	Free	Anticancer	Synthetic peptide	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =32 µM	NA	Lung	None
3266	22934601	2012	FLGALFHALSKLL	PTP-7a	13	Linear	L	None	Free	Free	Anticancer	Synthetic peptide	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =28 µM	NA	Lung	None
3265	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<40% cell viability at 50 µM	NA	Stomach	None
3264	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	100% cell viability at 5 µM	NA	Stomach	None
3263	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	<60% cell viability at 50 µM	NA	Blood	None
3262	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	100% cell viability at 5 µM	NA	Blood	None
3261	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	60% cell viability at 50 µM	NA	Colon	None
3260	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	>100% cell viability at 5 µM	NA	Colon	None
3259	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<20% cell viability at 50 µM	NA	Stomach	None
3258	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<100% cell viability at 5 µM	NA	Stomach	None
3257	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	<40% cell viability at 50 µM	NA	Blood	None
3256	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	100% cell viability at 5 µM	NA	Blood	None
3255	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	40% cell viability at 50 µM	NA	Colon	None
3254	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	100% cell viability at 5 µM	NA	Colon	None
3253	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ =12.55 µM	72-h	Ovary	None
3252	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ =22.25 µM	72-h	Skin	None
3251	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ =29.10 µM	72-h	Prostate	None
3250	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ =22.51 µM	72-h	Stomach	None
3249	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀ =14.80 µM	72-h	Colon	None
3248	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =14.53 µM	72-h	Lung	None
3247	22644847	2012	FLKWLFKWAKK	GA-K4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ =21.48 µM	72-h	Renal	None
3246	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀	72-h	Ovary	None
3245	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ =27.39 µM	72-h	Skin	None
3244	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ =47.69 µM	72-h	Prostate	None
3242	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀ =27.00 µM	72-h	Colon	None
3243	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ =26.70 µM	72-h	Stomach	None
3240	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ =41.21 µM	72-h	Renal	None
3241	22644847	2012	FLGWLFKWAKK	GA-K3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =25.20 µM	72-h	Lung	None
3238	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ =13.16 µM	72-h	Skin	None
3239	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ =14.58 µM	72-h	Ovary	None
3235	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀ =14.80 µM	72-h	Colon	None
3236	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ =13.77 µM	72-h	Stomach	None
3237	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ =24.32 µM	72-h	Prostate	None
3233	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ =22.59 µM	72-h	Renal	None
3234	22644847	2012	FLWWLFKWAWK	GA-W4	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =15.88 µM	72-h	Lung	None
3232	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ =22.06 µM	72-h	Ovary	None
3230	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ =46.51 µM	72-h	Prostate	None
3231	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ =13.97 µM	72-h	Skin	None
3229	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ =24.31 µM	72-h	Stomach	None
3228	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀ =24.63 µM	72-h	Colon	None
3227	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =20.36 µM	72-h	Lung	None
3226	22644847	2012	FLGWLFKWAWK	GA-W3	11	Linear	L	None	Amidation	Free	Antimicrobial	Undecapeptide analogues derived from Brevinin-1EMa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ =22.88 µM	72-h	Renal	None
3225	22413859	2012	KVKVKVKVPPTKVKVKVK	SVS-2	18	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	MDA-MB-436	Breast Cancer	MTT/MTS assay	IC₅₀ >100 µM	24-h	Breast	None
3224	22413859	2012	KVKVKVKVPPTKVKVKVK	SVS-2	18	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀ >100 µM	24-h	Breast	None
3223	22413859	2012	KVKVKVKVPPTKVKVKVK	SVS-2	18	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	KB	Oral Cancer	MTT/MTS assay	IC₅₀ >100 µM	24-h	Oral mucosa	None
3222	22413859	2012	KVKVKVKVPPTKVKVKVK	SVS-2	18	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ >100 µM	24-h	Lung	None
3221	22413859	2012	kvkvkvkvPptkvkvkvk	D-SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	MDA-MB-436	Breast Cancer	MTT/MTS assay	IC₅₀ =3.2±0.4 µM	24-h	Breast	None
3220	22413859	2012	kvkvkvkvPptkvkvkvk	D-SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀ =4.7±0.4 µM	24-h	Breast	None
3219	22413859	2012	kvkvkvkvPptkvkvkvk	D-SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	KB	Oral Cancer	MTT/MTS assay	IC₅₀ =4.5±0.5 µM	24-h	Oral mucosa	None
3218	22413859	2012	kvkvkvkvPptkvkvkvk	D-SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =3.2±0.6 µM	24-h	Lung	None
3217	22413859	2012	KVKVKVKVpPTKVKVKVK	SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	MDA-MB-436	Breast Cancer	MTT/MTS assay	IC₅₀ =5.6±0.5 µM	24-h	Breast	None
3216	22413859	2012	KVKVKVKVpPTKVKVKVK	SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	MCF-7	Breast Cancer	MTT/MTS assay	IC_{50_{=8.1±0.8 µM}}	24-h	Breast	None
3215	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	MDBK	Renal Cancer	MTT/MTS assay	NA	48-h	Renal	None
3213	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	MDBK	Renal Cancer	MTT/MTS assay	NA	48-h	Renal	None
3214	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	MDBK	Renal Cancer	MTT/MTS assay	NA	48-h	Renal	None
3211	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	MDBK	Renal Cancer	MTT/MTS assay	NA	48-h	Renal	None
3212	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	MDBK	Renal Cancer	MTT/MTS assay	NA	48-h	Renal	None
3210	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	Vero	Renal Cancer	MTT/MTS assay	NA	48-h	Renal	None
3208	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	CEF	Tumor	MTT/MTS assay	NA	48-h	Not Available	None
3207	22413859	2012	KVKVKVKVpPTKVKVKVK	SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Bovine lactoferrin (Lf-B)	KB	Oral Cancer	MTT/MTS assay	NA	24-h	Oral mucosa	None
3206	22413859	2012	KVKVKVKVpPTKVKVKVK	SVS-1	18	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic peptide	A-549	Lung Cancer	MTT/MTS assay	NA	24-h	Lung	None
3204	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	MDBK	Renal Cancer	MTT/MTS assay	NA	48-h	Renal	None
3205	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	MDBK	Renal Cancer	MTT/MTS assay	NA	48-h	Renal	None
3203	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	MDBK	Renal Cancer	MTT/MTS assay	NA	48-h	Renal	None
3201	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	MDBK	Renal Cancer	MTT/MTS assay	NA	48-h	Renal	None
3202	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	MDBK	Renal Cancer	MTT/MTS assay	NA	48-h	Renal	None
3198	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	CEF	Tumor	MTT/MTS assay	NA	48-h	Not Available	None
3200	22184121	2011	MTLTG	BPP-II	5	Linear	L	None	Free	Free	Antitumor	Immunomodulatory bursal-derived Pentapeptide-II	Vero	Renal Cancer	MTT/MTS assay	NA	48-h	Renal	None
3164	23301519	2013	RWRWRWRW	linear (RW)4-Dox	8	Linear	L	Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ]	Free	Free	Anticancer	Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP	MDA-MB-468	Breast Cancer	MTT/MTS assay	60-74% antiproliferative activity at 1 µM	72 to 120-h	Breast	None
3163	23301519	2013	RWRWRWRW	linear (RW)4-Dox	8	Linear	L	Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ]	Free	Free	Anticancer	Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP	HCT-116	Colon Cancer	MTT/MTS assay	21-61% antiproliferative activity at 1 µM	72 to 120-h	Colon	None
3161	23301519	2013	RWRWRWRW	linear (RW)4-Dox	8	Linear	L	Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ]	Free	Free	Anticancer	Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	46-69% antiproliferative activity at 1 µM	72 to 120-h	Blood	None
3162	23301519	2013	RWRWRWRW	linear (RW)4-Dox	8	Linear	L	Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ]	Free	Free	Anticancer	Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP	SK-OV-3	Ovarian Cancer	MTT/MTS assay	28-34% antiproliferative activity at 1 µM	72 to 120-h	Ovary	None
3160	23301519	2013	WRWRWRWRW	Cyclic [W(RW)4 ]-Dox	9	Cyclic	L	Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ]	Free	Free	Anticancer	Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP	MDA-MB-468	Breast Cancer	MTT/MTS assay	60-79% inhibition of cell proliferation at 1 µM	72 to 120-h	Breast	None
3156	23627474	2013	CHHNLTAAC	PTPRJ-pep19.7	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	20 ± 1.4% cell growth inhibition at 160 µM in 72 hours	72-h	Cervix	None
3157	23301519	2013	WRWRWRWRW	Cyclic [W(RW)4 ]-Dox	9	Cyclic	L	Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ]	Free	Free	Anticancer	Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	62-73% inhibition of cell proliferation at 1 µM	72 to 120-h	Blood	None
3158	23301519	2013	WRWRWRWRW	Cyclic [W(RW)4 ]-Dox	9	Cyclic	L	Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ]	Free	Free	Anticancer	Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP	SK-OV-3	Ovarian Cancer	MTT/MTS assay	51-74% inhibition of cell proliferation at 1 µM	72 to 120-h	Ovary	None
3159	23301519	2013	WRWRWRWRW	Cyclic [W(RW)4 ]-Dox	9	Cyclic	L	Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ]	Free	Free	Anticancer	Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP	HCT-116	Colon Cancer	MTT/MTS assay	50-67% inhibition of cell proliferation at 1 µM	72 to 120-h	Colon	None
3152	23627474	2013	CHHNATHAC	PTPRJ-pep19.5	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	2 ± 1.5% cell growth inhibition at 160 µM in 48 hours	48-h	Cervix	None
3153	23627474	2013	CHHNATHAC	PTPRJ-pep19.5	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	19 ± 4.2% cell growth inhibition at 160 µM in 72 hours	72-h	Cervix	None
3154	23627474	2013	CHHNLAHAC	PTPRJ-pep19.6	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	19 ± 4.2% cell growth inhibition at 160 µM in 72 hours	72-h	Cervix	None
3155	23627474	2013	CHHNLTAAC	PTPRJ-pep19.7	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	4.5 ± 2.13% cell growth inhibition at 160 µM in 48 hours	48-h	Cervix	None
3148	23627474	2013	CHANLTHAC	PTPRJ-pep19.3	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	51 ± 1.4% cell growth inhibition at 160 µM in 72 hours	72-h	Cervix	None
3149	23627474	2013	CHHALTHAC	PTPRJ-pep19.4	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	48.0 ± 2.82% cell growth inhibition at 160 µM in 24 hours	24-h	Cervix	None
3150	23627474	2013	CHHALTHAC	PTPRJ-pep19.4	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	62.5 ± 4.9% cell growth inhibition at 160 µM in 48 hours	48-h	Cervix	None
3151	23627474	2013	CHHALTHAC	PTPRJ-pep19.4	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	66.5 ± 2.12% cell growth inhibition at 160 µM in 72 hours	72-h	Cervix	None
3144	23627474	2013	CAHNLTHAC	PTPRJ-pep19.2	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	30 ± 2.82% cell growth inhibition at 160 µM in 48 hours	48-h	Cervix	None
3145	23627474	2013	CAHNLTHAC	PTPRJ-pep19.2	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	32.0 ± 4.2% cell growth inhibition at 160 µM in 72 hours	72-h	Cervix	None
3146	23627474	2013	CHANLTHAC	PTPRJ-pep19.3	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	28 ± 5.5% cell growth inhibition at 160 µM in 24 hours	24-h	Cervix	None
3147	23627474	2013	CHANLTHAC	PTPRJ-pep19.3	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	46 ± 4.2% cell growth inhibition at 160 µM in 48 hours	48-h	Cervix	None
3140	23627474	2013	CHHNLTHAC	PTPRJ-pep19	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	4.5 ± 0.1.4% cell growth inhibition at 160 µM in 48 hours	48-h	Cervix	None
3141	23627474	2013	CHHNLTHAC	PTPRJ-pep19	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	19 ± 2.82% cell growth inhibition at 160 µM in 72 hours	72-h	Cervix	None
3142	23627474	2013	CHHNLTHAC	PTPRJ-pep19.0	9	Linear	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	4 ± 1.4% cell growth inhibition at 160 µM in 72 hours	72-h	Cervix	None
3143	23627474	2013	CAHNLTHAC	PTPRJ-pep19.2	9	Cyclic(C1-C9)	L	None	Free	Free	Anticancer	PTPRJ agonist peptides	HeLa	Cervical Cancer	Trypan blue assay	16.5 ± 2.12% cell growth inhibition at 160 µM in 24 hours	24-h	Cervix	None
3137	23770440	2013	FLGMIPKLIKKLIKAFK	TsAP-S2	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀ = 1.8 µM	24-h	Breast	None
3138	23770440	2013	FLGMIPKLIKKLIKAFK	TsAP-S2	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 1.6 µM	24-h	Prostate	None
3139	23770440	2013	FLGMIPKLIKKLIKAFK	TsAP-S2	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	U251-MG	Brain Tumor	MTT/MTS assay	IC₅₀ = 2.0 µM	24-h	Brain	None
3135	23770440	2013	FLGMIPKLIKKLIKAFK	TsAP-S2	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	HI-57	Lung Cancer	MTT/MTS assay	IC₅₀ = 0.83 µM	24-h	Lung	None
3136	23770440	2013	FLGMIPKLIKKLIKAFK	TsAP-S2	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	H-838	Lung Cancer	MTT/MTS assay	IC₅₀ = 1.6 µM	24-h	Lung	None
3132	23770440	2013	FLSLIPKLVKKIIKAFK	TsAP-S1	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀ = 1.8 µM	24-h	Breast	None
3133	23770440	2013	FLSLIPKLVKKIIKAFK	TsAP-S1	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 2.1 µM	24-h	Prostate	None
3134	23770440	2013	FLSLIPKLVKKIIKAFK	TsAP-S1	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	U251-MG	Brain Tumor	MTT/MTS assay	IC₅₀ = 2.9 µM	24-h	Brain	None
3129	23770440	2013	FLGMIPGLIGGLISAFK	TsAP-2	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	U251-MG	Brain Tumor	MTT/MTS assay	IC₅₀ = 15.4 µM	24-h	Brain	None
3130	23770440	2013	FLSLIPKLVKKIIKAFK	TsAP-S1	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	HI-57	Lung Cancer	MTT/MTS assay	IC₅₀ = 1.5 µM	24-h	Lung	None
3131	23770440	2013	FLSLIPKLVKKIIKAFK	TsAP-S1	17	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of TsAP-1, Brazilian yellow scorpion venom peptide	H-838	Lung Cancer	MTT/MTS assay	IC₅₀ = 1.6 µM	24-h	Lung	None
3126	23770440	2013	FLGMIPGLIGGLISAFK	TsAP-2	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	H-838	Lung Cancer	MTT/MTS assay	IC₅₀ = 11.0 µM	24-h	Lung	None
3127	23770440	2013	FLGMIPGLIGGLISAFK	TsAP-2	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀ = 6.4 µM	24-h	Breast	None
3128	23770440	2013	FLGMIPGLIGGLISAFK	TsAP-2	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 13.3 µM	24-h	Prostate	None
3123	23770440	2013	FLSLIPSLVGGSISAFK	TsAP-1	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	HI-57	Lung Cancer	MTT/MTS assay	IC₅₀ =55.9 µM	24-h	Lung	None
3124	23770440	2013	FLSLIPSLVGGSISAFK	TsAP-1	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	H-838	Lung Cancer	MTT/MTS assay	IC₅₀ =52.5 µM	24-h	Lung	None
3125	23770440	2013	FLGMIPGLIGGLISAFK	TsAP-2	17	Linear	L	None	Amidation	Free	Antimicrobial	Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus	HI-57	Lung Cancer	MTT/MTS assay	IC₅₀ = 4.1 µM	24-h	Lung	None
3120	23993331	2013	KRLRRVWRRWR	MAP-04-04	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability >80% at 75 µM	48-h	Breast	None
3121	23993331	2013	KRLRRVWRRWR	MAP-04-04	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability >80% at 100 µM	48-h	Breast	None
3122	23993331	2013	KWLRRVWRWWR	MAP-04-03	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=61.5 µM	48-h	Breast	None
3116	23993331	2013	KWLRRVWRWWR	MAP-04-03	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability <40% at 75 µM	48-h	Breast	None
3117	23993331	2013	KWLRRVWRWWR	MAP-04-03	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability >20% at 100 µM	48-h	Breast	None
3118	23993331	2013	KWLRRVWRWWR	MAP-04-03	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability ~100% at 25 µM	48-h	Breast	None
3119	23993331	2013	KRLRRVWRRWR	MAP-04-04	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability >80% at 50 µM	48-h	Breast	None
3114	23993331	2013	KWLRRVWRWWR	MAP-04-03	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability >80% at 25 µM	48-h	Breast	None
3115	23993331	2013	KWLRRVWRWWR	MAP-04-03	11	Linear	L	None	Amidation	Free	Antimicrobial	Analogs of Ixosin-B amide	MCF-7	Breast Cancer	MTT/MTS assay	Cell viability ~50% at 50 µM	48-h	Breast	None
3112	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<100% cell viability at 5 µM	24-h	Stomach	None
3113	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<40% cell viability at 50 µM	24-h	Stomach	None
3109	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	60% cell viability at 50 µM	24-h	Colon	None
3110	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	100% cell viability at 5 µM	24-h	Blood	None
3111	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	<60% cell viability at 50 µM	24-h	Blood	None
3108	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	>100% cell viability at 5 µM	24-h	Colon	None
3107	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<20% cell viability at 50 µM	24-h	Stomach	None
3106	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<100% cell viability at 5 µM	24-h	Stomach	None
3105	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	<40% cell viability at 50 µM	24-h	Blood	None
3104	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	100% cell viability at 5 µM	24-h	Blood	None
3103	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	40% cell viability at 50 µM	24-h	Colon	None
3102	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	100% cell viability at 5 µM	24-h	Colon	None
3071	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	10 % Cytotoxicity at 3.125 mg/L	24-h	Fibrous connective tissue	None
3070	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	1 % Cytotoxicity at 6.25 mg/L	24-h	Fibrous connective tissue	None
3069	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	20 % Cytotoxicity at 12.5 mg/L	24-h	Fibrous connective tissue	None
3068	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 25 mg/L	24-h	Fibrous connective tissue	None
3067	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	24-h	Fibrous connective tissue	None
3066	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	15 % Cytotoxicity at 3.125 mg/L	12-h	Fibrous connective tissue	None
3065	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	35 % Cytotoxicity at 6.25 mg/L	12-h	Fibrous connective tissue	None
3064	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 12.5 mg/L	12-h	Fibrous connective tissue	None
3063	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	85 % Cytotoxicity at 25 mg/L	12-h	Fibrous connective tissue	None
3062	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	12-h	Fibrous connective tissue	None
3061	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	35 % Cytotoxicity at 3.125 mg/L	6-h	Fibrous connective tissue	None
3060	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 6.25 mg/L	6-h	Fibrous connective tissue	None
3059	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	48 % Cytotoxicity at 12.5 mg/L	6-h	Fibrous connective tissue	None
3058	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	84% Cytotoxicity at 25 mg/L	6-h	Fibrous connective tissue	None
3057	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	84 % Cytotoxicity at 50 mg/L	6-h	Fibrous connective tissue	None
3056	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	25 % Cytotoxicity at 3.125 mg/L	3-h	Fibrous connective tissue	None
3055	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
3054	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	45 % Cytotoxicity at 12.5 mg/L	3-h	Fibrous connective tissue	None
3053	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	85 % Cytotoxicity at 25 mg/L	3-h	Fibrous connective tissue	None
3052	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	80 % Cytotoxicity at 50 mg/L	3-h	Fibrous connective tissue	None
3051	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	18 % Cytotoxicity at 3.125 mg/L	24-h	Cervix	None
3050	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	18 % Cytotoxicity at 6.25 mg/L	24-h	Cervix	None
3049	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	18 % Cytotoxicity at 12.5 mg/L	24-h	Cervix	None
3048	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	82 % Cytotoxicity at 25 mg/L	24-h	Cervix	None
3047	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	24-h	Cervix	None
3046	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	10 % Cytotoxicity at 3.125 mg/L	12-h	Cervix	None
3045	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	4 % Cytotoxicity at 6.25 mg/L	12-h	Cervix	None
3044	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	18 % Cytotoxicity at 12.5 mg/L	12-h	Cervix	None
3043	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	12-h	Cervix	None
3042	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	82 % Cytotoxicity at 50 mg/L	12-h	Cervix	None
3041	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	5 % Cytotoxicity at 3.125 mg/L	6-h	Cervix	None
3040	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	10 % Cytotoxicity at 6.25 mg/L	6-h	Cervix	None
3039	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	10 % Cytotoxicity at 12.5 mg/L	6-h	Cervix	None
3038	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	6-h	Cervix	None
3037	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	78 % Cytotoxicity at 50 mg/L	6-h	Cervix	None
3036	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	1 % Cytotoxicity at 3.125 mg/L	3-h	Cervix	None
3035	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	5 % Cytotoxicity at 6.25 mg/L	3-h	Cervix	None
3034	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	4 % Cytotoxicity at 12.5 mg/L	3-h	Cervix	None
3033	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	60 % Cytotoxicity at 25 mg/L	3-h	Cervix	None
3032	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	70 % Cytotoxicity at 50 mg/L	3-h	Cervix	None
3031	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	10 % Cytotoxicity at 3.125 mg/L	24-h	Fibrous connective tissue	None
3030	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	5 % Cytotoxicity at 6.25 mg/L	24-h	Fibrous connective tissue	None
3028	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 25 mg/L	24-h	Fibrous connective tissue	None
3029	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	15 % Cytotoxicity at 12.5 mg/L	24-h	Fibrous connective tissue	None
3027	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	24-h	Fibrous connective tissue	None
3026	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	38 % Cytotoxicity at 3.125 mg/L	12-h	Fibrous connective tissue	None
3024	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	39 % Cytotoxicity at 12.5 mg/L	12-h	Fibrous connective tissue	None
3025	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	28 % Cytotoxicity at 6.25 mg/L	12-h	Fibrous connective tissue	None
3023	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	95 % Cytotoxicity at 25 mg/L	12-h	Fibrous connective tissue	None
3021	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 3.125 mg/L	6-h	Fibrous connective tissue	None
3022	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	97 % Cytotoxicity at 50 mg/L	12-h	Fibrous connective tissue	None
3020	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 6.25 mg/L	6-h	Fibrous connective tissue	None
3019	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 12.5 mg/L	6-h	Fibrous connective tissue	None
3018	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 25 mg/L	6-h	Fibrous connective tissue	None
3017	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	6-h	Fibrous connective tissue	None
3016	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	35 % Cytotoxicity at 3.125 mg/L	3-h	Fibrous connective tissue	None
3015	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	35 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
3014	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	40 % Cytotoxicity at 12.5 mg/L	3-h	Fibrous connective tissue	None
3013	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	82 % Cytotoxicity at 25 mg/L	3-h	Fibrous connective tissue	None
3012	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	88 % Cytotoxicity at 50 mg/L	3-h	Fibrous connective tissue	None
3011	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	5 % Cytotoxicity at 3.125 mg/L	24-h	Cervix	None
3010	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	12 % Cytotoxicity at 6.25 mg/L	24-h	Cervix	None
3009	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	15 % Cytotoxicity at 12.5 mg/L	24-h	Cervix	None
3008	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	80 % Cytotoxicity at 25 mg/L	24-h	Cervix	None
3007	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	24-h	Cervix	None
3006	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	10 % Cytotoxicity at 3.125 mg/L	12-h	Cervix	None
3005	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	5 % Cytotoxicity at 6.25 mg/L	12-h	Cervix	None
3004	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	4 % Cytotoxicity at 12.5 mg/L	12-h	Cervix	None
3003	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	68 % Cytotoxicity at 25 mg/L	12-h	Cervix	None
3002	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	78 % Cytotoxicity at 50 mg/L	12-h	Cervix	None
3001	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	4 % Cytotoxicity at 3.125 mg/L	6-h	Cervix	None
3000	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	6-h	Cervix	None
2999	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	75 % Cytotoxicity at 50 mg/L	6-h	Cervix	None
2998	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	4 % Cytotoxicity at 12.5 mg/L	3-h	Cervix	None
2997	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	44 % Cytotoxicity at 25 mg/L	3-h	Cervix	None
2996	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin-1	33	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	62 % Cytotoxicity at 50 mg/L	3-h	Cervix	None
2994	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	3 % Cytotoxicity at 6.25 mg/L	24-h	Fibrous connective tissue	None
2995	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	3 % Cytotoxicity at 3.125 mg/L	24-h	Fibrous connective tissue	None
2993	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	8 % Cytotoxicity at 12.5 mg/L	24-h	Fibrous connective tissue	None
2992	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	75 % Cytotoxicity at 25 mg/L	24-h	Fibrous connective tissue	None
2990	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	4 % Cytotoxicity at 3.125 mg/L	12-h	Fibrous connective tissue	None
2991	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	24-h	Fibrous connective tissue	None
2989	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	4 % Cytotoxicity at 6.25 mg/L	12-h	Fibrous connective tissue	None
2988	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	12 % Cytotoxicity at 12.5 mg/L	12-h	Fibrous connective tissue	None
2986	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	76 % Cytotoxicity at 50 mg/L	12-h	Fibrous connective tissue	None
2987	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	12-h	Fibrous connective tissue	None
2985	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	10 % Cytotoxicity at 3.125 mg/L	6-h	Fibrous connective tissue	None
2983	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	5 %Cytotoxicity at 12.5 mg/L	6-h	Fibrous connective tissue	None
2984	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	7 % Cytotoxicity at 6.25 mg/L	6-h	Fibrous connective tissue	None
2982	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	6-h	Fibrous connective tissue	None
2980	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	5 % Cytotoxicity at 3.125 mg/L	3-h	Fibrous connective tissue	None
2981	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	75 % Cytotoxicity at 50 mg/L	6-h	Fibrous connective tissue	None
2979	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	10 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
2978	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	8 % Cytotoxicity at 12.5 mg/L	3-h	Fibrous connective tissue	None
2976	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	60 % Cytotoxicity at 50 mg/L	3-h	Fibrous connective tissue	None
2977	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	50 % Cytotoxicity at 25 mg/L	3-h	Fibrous connective tissue	None
2973	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	8 % Cytotoxicity at 12.5 mg/L	24-h	Cervix	None
2974	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	3 % Cytotoxicity at 6.25 mg/L	24-h	Cervix	None
2975	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	3 % Cytotoxicity at 3.125 mg/L	24-h	Cervix	None
2972	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	75 % Cytotoxicity at 25 mg/L	24-h	Cervix	None
2970	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	4 % Cytotoxicity at 3.125 mg/L	12-h	Cervix	None
2971	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	24-h	Cervix	None
2969	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	4 % Cytotoxicity at 6.25 mg/L	12-h	Cervix	None
2967	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	12-h	Cervix	None
2968	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	12 % Cytotoxicity at 12.5 mg/L	12-h	Cervix	None
2965	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	10 % Cytotoxicity at 3.125 mg/L	6-h	Cervix	None
2966	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	76 % Cytotoxicity at 50 mg/L	12-h	Cervix	None
2963	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	5 % Cytotoxicity at 12.5 mg/L	6-h	Cervix	None
2964	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	7 % Cytotoxicity at 6.25 mg/L	6-h	Cervix	None
2962	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	6-h	Cervix	None
2961	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	75 % Cytotoxicity at 50 mg/L	6-h	Cervix	None
2959	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	10 % Cytotoxicity at 6.25 mg/L	3-h	Cervix	None
2960	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	5 % Cytotoxicity at 3.125 mg/L	3-h	Cervix	None
2958	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	8 % Cytotoxicity at 12.5 mg/L	3-h	Cervix	None
2957	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	50 % Cytotoxicity at 25 mg/L	3-h	Cervix	None
2956	23598079	2013	FIFHIIKGLFHAGKMI	Epinecidin-8	16	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	60 % Cytotoxicity at 50 mg/L	3-h	Cervix	None
2955	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	28 % Cytotoxicity at 3.125 mg/L	24-h	Fibrous connective tissue	None
2954	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 6.25 mg/L	24-h	Fibrous connective tissue	None
2952	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	85 % Cytotoxicity at 25 mg/L	24-h	Fibrous connective tissue	None
2953	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	38 % Cytotoxicity at 12.5 mg/L	24-h	Fibrous connective tissue	None
2951	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	84 % Cytotoxicity at 50 mg/L	24-h	Fibrous connective tissue	None
2950	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	28 % Cytotoxicity at 3.125 mg/L	12-h	Fibrous connective tissue	None
2949	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 6.25 mg/L	12-h	Fibrous connective tissue	None
2948	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	46 % Cytotoxicity at 12.5 mg/L	12-h	Fibrous connective tissue	None
2947	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	96 % Cytotoxicity at 25 mg/L	12-h	Fibrous connective tissue	None
2946	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	95 % Cytotoxicity at 50 mg/L	12-h	Fibrous connective tissue	None
2945	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	25 % Cytotoxicity at 3.125 mg/L	6-h	Fibrous connective tissue	None
2944	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	25 % Cytotoxicity at 6.25 mg/L	6-h	Fibrous connective tissue	None
2943	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	45 % Cytotoxicity at 12.5 mg/L	6-h	Fibrous connective tissue	None
2942	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	95 % Cytotoxicity at 25 mg/L	6-h	Fibrous connective tissue	None
2941	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	6-h	Fibrous connective tissue	None
2940	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	41 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
2939	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	41 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
2938	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	41 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
2937	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	39 % Cytotoxicity at 3.125 mg/L	3-h	Fibrous connective tissue	None
2936	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	41 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
2935	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	42 % Cytotoxicity at 12.5 mg/L	3-h	Fibrous connective tissue	None
2934	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	85 % Cytotoxicity at 25 mg/L	3-h	Fibrous connective tissue	None
2933	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	82 % Cytotoxicity at 50 mg/L	3-h	Fibrous connective tissue	None
2932	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	77 % Cytotoxicity at 25 mg/L	24-h	Cervix	None
2931	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	83% Cytotoxicity at 50 mg/L	24-h	Cervix	None
2930	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	65% Cytotoxicity at 25 mg/L	12-h	Cervix	None
2929	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	75 % Cytotoxicity at 50 mg/L	12-h	Cervix	None
2928	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	65% Cytotoxicity at 25 mg/L	6-h	Cervix	None
2927	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	75% Cytotoxicity at 50 mg/L	6-h	Cervix	None
2926	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	38% Cytotoxicity at 25 mg/L	3-h	Cervix	None
2925	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	45% Cytotoxicity at 50 mg/L	3-h	Cervix	None
2924	21849092	2011	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	COLO-587	Human epithelial Cancer	WST-1 assay	IC₅₀=6.4 µM	72-h	Pancreatic	None
2923	21849092	2011	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	LNCaP	Prostate Cancer	WST-1 assay	IC₅₀= 6.2 µM	72-h	Prostate	None
2922	21849092	2011	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	HuCCT-1	Human epithelial Cancer	WST-1 assay	IC₅₀= 8.3 µM	72-h	Bileduct	None
2921	21849092	2011	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	U-251	Brain Tumor	WST-1 assay	IC₅₀=7.0 µM	72-h	Brain	None
2920	21849092	2011	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	SN-19	Brain Tumor	WST-1 assay	IC₅₀= 7.8 µM	72-h	Brain	None
2919	21849092	2011	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	SF-295	Brain Tumor	WST-1 assay	IC₅₀= 6.3 µM	72-h	Brain	None
2918	21849092	2011	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	ZR75-1	Breast Cancer	WST-1 assay	IC₅₀= 9.3 µM	72-h	Breast	None
2917	21849092	2011	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	BT-20	Breast Cancer	WST-1 assay	IC₅₀= 4.8 µM	72-h	Breast	None
2916	21849092	2011	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	MDA-MB-231	Breast Cancer	WST-1 assay	IC₅₀= 7.8 µM	72-h	Breast	None
2915	21849092	2011	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	SK-BR-3	Breast Cancer	WST-1 assay	IC₅₀= 6.5 µM	72-h	Breast	None
2914	21849092	2011	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	T-47D	Breast Cancer	WST-1 assay	IC₅₀= 4.0 µM	72-h	Breast	None
2913	21849092	2011	THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK	Transferrin receptor (TfR)-lytic hybrid peptide	32	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	BT-474	Breast Cancer	WST-1 assay	IC₅₀= 8.8 µM	72-h	Breast	None
2911	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	LNCaP	Prostate Cancer	WST-1 assay	IC₅₀= 15.8 µM	72-h	Prostate	None
2912	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	COLO-587	Human epithelial Cancer	WST-1 assay	IC₅₀= 13.5 µM	72-h	Pancreatic	None
2910	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	HuCCT-1	Human epithelial Cancer	WST-1 assay	IC₅₀= 17.1 µM	72-h	Bileduct	None
2909	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	U-251	Brain Tumor	WST-1 assay	IC₅₀= 17.0 µM	72-h	Brain	None
2907	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	SF-295	Brain Tumor	WST-1 assay	IC₅₀= 19.1 µM	72-h	Brain	None
2908	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	SN-19	Brain Tumor	WST-1 assay	IC₅₀= 21.9 µM	72-h	Brain	None
2906	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	ZR75-1	Breast Cancer	WST-1 assay	IC₅₀= 19.4 µM	72-h	Breast	None
2905	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	BT-20	Breast Cancer	WST-1 assay	IC₅₀= 20.0 µM	72-h	Breast	None
2904	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	MDA-MB-231	Breast Cancer	WST-1 assay	IC₅₀= 27.0 µM	72-h	Breast	None
2903	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	SK-BR-3	Breast Cancer	WST-1 assay	IC₅₀= 25.7 µM	72-h	Breast	None
2902	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	T-47D	Breast Cancer	WST-1 assay	IC₅₀= 14.1 µM	72-h	Breast	None
2901	21849092	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Transferrin receptor (TfR)	BT-474	Breast Cancer	WST-1 assay	IC₅₀= 34.5 µM	72-h	Breast	None
2877	23583573	2013	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	Bcap-37	Breast Cancer	MTT/MTS assay	30 % Cell viability at 40 µM	1-h	Breast	None
2876	23583573	2013	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	Bcap-37	Breast Cancer	MTT/MTS assay	45% Cell viability at 30 µM	1-h	Breast	None
2874	23583573	2013	DEVD	caspase 3 inhibitor	4	Linear	L	None	Fluoromethyl ketone(fmk)	Free	Anticancer	caspase 3 inhibitor	Bcap-37	Breast Cancer	MTT/MTS assay	35 % Cell viability at 40 µM	1-h	Breast	None
2875	23583573	2013	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	Bcap-37	Breast Cancer	MTT/MTS assay	70% Cell viability at 20 µM	1-h	Breast	None
2872	23583573	2013	DEVD	caspase 3 inhibitor	4	Linear	L	None	Fluoromethyl ketone(fmk)	Free	Anticancer	caspase 3 inhibitor	Bcap-37	Breast Cancer	MTT/MTS assay	65% Cell viability at 20 µM	1-h	Breast	None
2873	23583573	2013	DEVD	caspase 3 inhibitor	4	Linear	L	None	Fluoromethyl ketone(fmk)	Free	Anticancer	caspase 3 inhibitor	Bcap-37	Breast Cancer	MTT/MTS assay	40% Cell viability at 30 µM	1-h	Breast	None
2868	22084165	2011	KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK	IL-4RaÐlytic hybrid peptide	33	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	MDA-MB-231	Breast Cancer	WST-1 assay	IC₅₀=5.7 µMol/L	24-h	Breast	None
2867	22084165	2011	KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK	IL-4RaÐlytic hybrid peptide	33	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	H-322	Lung Cancer	WST-1 assay	IC₅₀=3.6 µMol/L	24-h	Lung	None
2866	22084165	2011	KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK	IL-4RaÐlytic hybrid peptide	33	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	A-172	Brain Tumor	WST-1 assay	IC₅₀=6.8 µMol/L	24-h	Brain	None
2865	22084165	2011	KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK	IL-4RaÐlytic hybrid peptide	33	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	T98G	Brain Tumor	WST-1 assay	IC₅₀=18.5 µMol/L	24-h	Brain	None
2864	22084165	2011	KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK	IL-4RaÐlytic hybrid peptide	33	Linear	Mix	None	Free	Free	Anticancer	Bovine lactoferrin (Lf-B)	KB	Oral Cancer	WST-1 assay	IC₅₀=13.2 µMol/L	24-h	Oral mucosa	None
2863	22084165	2011	KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK	IL-4RaÐlytic hybrid peptide	33	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	SU.86.86	Pancreatic Cancer	WST-1 assay	IC₅₀=7.5 µMol/L	24-h	Pancreatic	None
2862	22084165	2011	KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK	IL-4RaÐlytic hybrid peptide	33	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	BXPC-3	Pancreatic Cancer	WST-1 assay	IC₅₀=6.8 µMol/L	24-h	Pancreatic	None
2861	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	MDA-MB-231	Breast Cancer	WST-1 assay	IC₅₀=18.5 µMol/L	24-h	Breast	None
2860	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	H-322	Lung Cancer	WST-1 assay	IC₅₀=27.1 µMol/L	24-h	Lung	None
2859	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	A-172	Brain Tumor	WST-1 assay	IC₅₀=30.5 µMol/L	24-h	Brain	None
2858	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	T98G	Brain Tumor	WST-1 assay	IC₅₀=77.3 µMol/L	24-h	Brain	None
2857	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Bovine lactoferrin (Lf-B)	KB	Oral Cancer	WST-1 assay	IC₅₀=37.4 µMol/L	24-h	Oral mucosa	None
2856	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	SU.86.86	Pancreatic Cancer	WST-1 assay	IC₅₀=28.0 µMol/L	24-h	Pancreatic	None
2855	22084165	2011	KLlLKlLkkLLKlLKKK	Lytik	17	Linear	Mix	None	Free	Free	Anticancer	Interleukin-4 receptor a (IL-4Ra) chain	BXPC-3	Pancreatic Cancer	WST-1 assay	IC₅₀=37.1 µMol/L	24-h	Pancreatic	None
2854	23577112, 21871946	2012	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	MCF-7	Breast Cancer	LDH leakage assay	32% Cytotoxicity at 40 µM	1-h	Breast	None
2853	23577112, 21871946	2012	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	MCF-7	Breast Cancer	MTT/MTS assay	61% Cell viability at 40 µM	1-h	Breast	None
2851	23577112, 21871946	2012	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	MDA-MB-231	Breast Cancer	MTT/MTS assay	22% Cell viability at 40 µM	1-h	Breast	None
2852	23577112, 21871946	2012	FVDLKKIANIINSIF	Tempoprin-1CEa	15	Linear	L	None	Amidation	Free	Antimicrobial	Chinese brown frog Rana chensinensis.	MDA-MB-231	Breast Cancer	LDH leakage assay	61% Cytotoxicity at 40 µM	1-h	Breast	None
2850	23028527	2012	GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV	Adenoregulin	33	Linear	L	None	Free	Free	Antimicrobial	South American frog Phyllomedusa bicolor	Raji	Lymphoma Cancer	LDH leakage assay	GI₅₀ =2.57±0.75 µM	24-h	Blood	None
2849	23028527	2012	GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV	Adenoregulin	33	Linear	L	None	Free	Free	Antimicrobial	South American frog Phyllomedusa bicolor	MDA-MB-231	Breast Cancer	LDH leakage assay	GI₅₀ =8.06±0.50 µM	24-h	Breast	None
2848	23028527	2012	GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV	Adenoregulin	33	Linear	L	None	Free	Free	Antimicrobial	South American frog Phyllomedusa bicolor	DU-145	Liver Cancer	LDH leakage assay	GI₅₀ =0.91±0.04 µM	24-h	Prostate	None
2847	23028527	2012	GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV	Adenoregulin	33	Linear	L	None	Free	Free	Antimicrobial	South American frog Phyllomedusa bicolor	LNCaP	Prostate Cancer	LDH leakage assay	GI₅₀ =0.31±0.15 µM	24-h	Prostate	None
2846	23028527	2012	GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV	Adenoregulin	33	Linear	L	None	Free	Free	Antimicrobial	South American frog Phyllomedusa bicolor	PC-3	Prostate Cancer	LDH leakage assay	GI₅₀ =1.24±0.23 µM	24-h	Prostate	None
2844	24246647	2014	GIIKKIIKKIIKKIIKKI	Short α-helical peptides	18	Linear	L	None	Amidation	Free	Antimicrobial	Alpha-helical proteins	HL-60	Leukemia Cancer	MTT/MTS assay	70% Cytotoxicity at 5 µM Approx	24-h	Blood	None
2843	24246647	2014	GIIKKIIKKIIKKI	Short α-helical peptides	14	Linear	L	None	Amidation	Free	Antimicrobial	Alpha-helical proteins	HL-60	Leukemia Cancer	MTT/MTS assay	90% Cytotoxicity at 5 µM Approx	24-h	Blood	None
2842	24246647	2014	GIIKKIIKKI	Short α-helical peptides	10	Linear	L	None	Amidation	Free	Antimicrobial	Alpha-helical proteins	HL-60	Leukemia Cancer	MTT/MTS assay	100% Cytotoxicity at 5 µM Approx	24-h	Blood	None
2840	24246647	2014	GIIKKIIKKIIKKI	Short α-helical peptides	14	Linear	L	None	Amidation	Free	Antimicrobial	Alpha-helical proteins	HeLa	Cervical Cancer	MTT/MTS assay	95% Cytotoxicity at 4 µM Approx	24-h	Cervix	None
2841	24246647	2014	GIIKKIIKKIIKKIIKKI	Short α-helical peptides	18	Linear	L	None	Amidation	Free	Antimicrobial	Alpha-helical proteins	HeLa	Cervical Cancer	MTT/MTS assay	80% Cytotoxicity at 4 µM Approx	24-h	Cervix	None
2839	24246647	2014	GIIKKIIKKI	Short α-helical peptides	10	Linear	L	None	Amidation	Free	Antimicrobial	Alpha-helical proteins	HeLa	Cervical Cancer	MTT/MTS assay	99% Cytotoxicity at 4 µM Approx	24-h	Cervix	None
2834	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	J774A.1	Tumor	MTT/MTS assay	IC₅₀=12 µM	96-h	Blood	None
2835	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	J774A.1	Tumor	MTT/MTS assay	IC₅₀=17 µM	96-h	Blood	None
2833	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	J774A.1	Tumor	MTT/MTS assay	IC₅₀=26 µM	24-h	Blood	None
2832	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	J774A.1	Tumor	MTT/MTS assay	IC₅₀=47 µM	24-h	Blood	None
2831	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=36 µM	96-h	Blood	None
2830	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=25 µM	96-h	Blood	None
2829	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=45 µM	72-h	Blood	None
2828	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=36 µM	72-h	Blood	None
2827	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=43 µM	48-h	Blood	None
2826	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=37 µM	48-h	Blood	None
2825	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=43 µM	24-h	Blood	None
2824	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=39 µM	24-h	Blood	None
2823	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=38 µM	2-h	Blood	None
2822	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	HUT-102	Lymphoma Cancer	MTT/MTS assay	IC₅₀=93 µM	2-h	Blood	None
2821	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=10 µM	48-h	Breast	None
2820	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=16 µM	48-h	Breast	None
2819	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=12 µM	24-h	Breast	None
2818	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=29 µM	24-h	Breast	None
2817	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=18 µM	2-h	Breast	None
2816	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=39 µM	2-h	Breast	None
2815	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	LNCaP	Prostate Cancer	MTT/MTS assay	IC₅₀=8 µM	48-h	Prostate	None
2814	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	LNCaP	Prostate Cancer	MTT/MTS assay	IC₅₀=28 µM	48-h	Prostate	None
2812	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	LNCaP	Prostate Cancer	MTT/MTS assay	IC₅₀=23 µM	24-h	Prostate	None
2813	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	LNCaP	Prostate Cancer	MTT/MTS assay	IC₅₀=9 µM	24-h	Prostate	None
2810	23000474	2012	RRRRRNWMWC	9R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	LNCaP	Prostate Cancer	MTT/MTS assay	IC₅₀=44 µM	2-h	Prostate	None
2811	23000474	2012	RRRRRWCMNW	9S1R	10	Linear	L	None	Free	Free	Anticancer	Nullomer derived anticancer peptides (NulloPs):	LNCaP	Prostate Cancer	MTT/MTS assay	IC₅₀=26 µM	2-h	Prostate	None
1772	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 14.58 mM	24-h	Ovary	WO_2007133033_A1
1771	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 13.16 mM	24-h	Skin	WO_2007133033_A1
1770	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 24.32 mM	24-h	Prostate	WO_2007133033_A1
1769	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	IC₅₀ = 57 mM	24-h	Colon	WO_2007133033_A1
1768	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 13.77 mM	24-h	Stomach	WO_2007133033_A1
1767	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 14.8 mM	24-h	Colon	WO_2007133033_A1
1766	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 15.88 mM	24-h	Lung	WO_2007133033_A1
1765	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	Not Available	24-h	Renal	WO_2007133033_A1
1764	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 22.06 mM	24-h	Ovary	WO_2007133033_A1
1763	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 13.97 mM	24-h	Skin	WO_2007133033_A1
1762	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 46.51 mM	24-h	Prostate	WO_2007133033_A1
1761	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	IC₅₀ = 48 mM	24-h	Colon	WO_2007133033_A1
1760	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 22.31 mM	24-h	Stomach	WO_2007133033_A1
1759	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 24.63 mM	24-h	Colon	WO_2007133033_A1
1758	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 20.36 mM	24-h	Lung	WO_2007133033_A1
1757	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	Not Available	24-h	Renal	WO_2007133033_A1
1756	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 12.55 mM	24-h	Ovary	WO_2007133033_A1
1755	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 22.25 mM	24-h	Skin	WO_2007133033_A1
1754	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 29.1 mM	24-h	Prostate	WO_2007133033_A1
1753	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	WO_2007133033_A1
1752	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 22.51 mM	24-h	Stomach	WO_2007133033_A1
1751	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 14.8 mM	24-h	Colon	WO_2007133033_A1
1750	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 14.53 mM	24-h	Lung	WO_2007133033_A1
1749	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ = 21.48 mM	24-h	Renal	WO_2007133033_A1
1748	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 24.76 mM	24-h	Ovary	WO_2007133033_A1
1747	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 27.39 mM	24-h	Skin	WO_2007133033_A1
1746	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 47.69 mM	24-h	Prostate	WO_2007133033_A1
1745	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	WO_2007133033_A1
1744	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 26.7 mM	24-h	Stomach	WO_2007133033_A1
1743	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 25.2 mM	24-h	Lung	WO_2007133033_A1
1742	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ = 41.21 mM	24-h	Renal	WO_2007133033_A1
1741	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	IC₅₀ = 57 mM	24-h	Colon	US_008076284_B2
1740	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	IC₅₀ = 48 mM	24-h	Colon	US_008076284_B2
1739	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_008076284_B2
1738	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	NCI-H630	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_008076284_B2
1737	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 14.8 mM	24-h	Colon	US_008076284_B2
1736	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 24.63 mM	24-h	Colon	US_008076284_B2
1735	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 14.8 mM	24-h	Colon	US_008076284_B2
1734	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	HCTl-16	Colon Cancer	MTT/MTS assay	IC₅₀ = 27 mM	24-h	Colon	US_008076284_B2
1733	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	Not Available	24-h	Renal	US_008076284_B2
1732	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 24.32 mM	24-h	Prostate	US_008076284_B2
1731	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 13.77 mM	24-h	Stomach	US_008076284_B2
1730	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 14.58 mM	24-h	Ovary	US_008076284_B2
1729	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 14.8 mM	24-h	Lung	US_008076284_B2
1728	None	2011	FLWWLFKWAWK	Gaegurin peptides SEQID NO: 4	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 13.16 mM	24-h	Skin	US_008076284_B2
1727	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	Not Available	24-h	Renal	US_008076284_B2
1726	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 46.51 mM	24-h	Prostate	US_008076284_B2
1725	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 24.31 mM	24-h	Stomach	US_008076284_B2
1724	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 22.06 mM	24-h	Ovary	US_008076284_B2
1723	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 20.36 mM	24-h	Lung	US_008076284_B2
1722	None	2011	FLGWLFKWAWK	Gaegurin peptides SEQID NO: 3	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 13.97 mM	24-h	Skin	US_008076284_B2
1721	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ = 21.48 mM	24-h	Renal	US_008076284_B2
1720	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 29.1 mM	24-h	Prostate	US_008076284_B2
1719	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 22.51 mM	24-h	Stomach	US_008076284_B2
1718	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 12.55 mM	24-h	Ovary	US_008076284_B2
1717	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 14.53 mM	24-h	Lung	US_008076284_B2
1716	None	2011	FLKWLFKWAKK	Gaegurin peptides SEQID NO: 2	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 22.25 mM	24-h	Skin	US_008076284_B2
1715	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-498	Renal Cancer	MTT/MTS assay	IC₅₀ = 41.21 mM	24-h	Renal	US_008076284_B2
1714	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀ = 47.69 mM	24-h	Prostate	US_008076284_B2
1713	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	MKN-45	Gastric Cancer	MTT/MTS assay	IC₅₀ = 26.7 mM	24-h	Stomach	US_008076284_B2
1712	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀ = 24.76 mM	24-h	Ovary	US_008076284_B2
1710	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀ = 27.39 mM	24-h	Skin	US_008076284_B2
1711	None	2011	FLGWLFKWAKK	Gaegurin peptides SEQID NO: 1	11	Linear	L	None	Free	Free	Antimicrobial	Korean frog Rana rugosa	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ = 25.2 mM	24-h	Lung	US_008076284_B2
1705	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	MEC	Breast Cancer	MTT/MTS assay	29.33 Inhibition ratio at 50 µg/ml	24-h	Breast	None
1704	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	MEC	Breast Cancer	MTT/MTS assay	19.76 Inhibition ratio at 50 µg/ml	24-h	Breast	None
1703	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	MEC	Breast Cancer	MTT/MTS assay	27.99 Inhibition ratio at 50 µg/ml	24-h	Breast	None
1702	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	MEC	Breast Cancer	MTT/MTS assay	24.15Inhibition ratio at 50 µg/ml	24-h	Breast	None
1701	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	HEK-293T	Renal Cancer	MTT/MTS assay	32.52 Inhibition ratio at 50 µg/ml	24-h	Renal	None
1700	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	HEK-293T	Renal Cancer	MTT/MTS assay	27.86 Inhibition ratio at 50 µg/ml	24-h	Renal	None
1699	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HEK-293T	Renal Cancer	MTT/MTS assay	30.90 Inhibition ratio at 50 µg/ml	24-h	Renal	None
1698	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HEK-293T	Renal Cancer	MTT/MTS assay	30.82 Inhibition ratio at 50 µg/ml	24-h	Renal	None
1697	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	HL7702	Liver Cancer	MTT/MTS assay	38.13 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1696	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	HL7702	Liver Cancer	MTT/MTS assay	36.25 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1695	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HL7702	Liver Cancer	MTT/MTS assay	37.00 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1694	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HL7702	Liver Cancer	MTT/MTS assay	37.22 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1693	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	A-549	Lung Cancer	MTT/MTS assay	52.50 Inhibition ratio at 50 µg/ml	24-h	Lung	None
1692	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	A-549	Lung Cancer	MTT/MTS assay	47.26Inhibition ratio at 50 µg/ml	24-h	Lung	None
1691	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	A-549	Lung Cancer	MTT/MTS assay	50.64 Inhibition ratio at 50 µg/ml	24-h	Lung	None
1690	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	A-549	Lung Cancer	MTT/MTS assay	45.62 Inhibition ratio at 50 µg/ml	24-h	Lung	None
1689	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	BGC-823	Gastric Cancer	MTT/MTS assay	73.705 Inhibition ratio at 50 µg/ml	24-h	Stomach	None
1688	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	BGC-823	Gastric Cancer	MTT/MTS assay	62.49 Inhibition ratio at 50 µg/ml	24-h	Stomach	None
1687	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	BGC-823	Gastric Cancer	MTT/MTS assay	50.85 Inhibition ratio at 50 µg/ml	24-h	Stomach	None
1686	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	BGC-823	Gastric Cancer	MTT/MTS assay	48.19 Inhibition ratio at 50 µg/ml	24-h	Stomach	None
1685	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide aNot Available temporins	HepG-2	Liver Cancer	MTT/MTS assay	73.07 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1684	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide aNot Available temporins	HepG-2	Liver Cancer	MTT/MTS assay	60.22 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1683	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HepG-2	Liver Cancer	MTT/MTS assay	55.98 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1682	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HepG-2	Liver Cancer	MTT/MTS assay	50.90 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1681	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	HeLa	Cervical Cancer	MTT/MTS assay	78.045 Inhibition ratio at 50 µg/ml	24-h	Cervix	None
1680	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	HeLa	Cervical Cancer	MTT/MTS assay	73.09 Inhibition ratio at 50 µg/ml	24-h	Cervix	None
1679	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HeLa	Cervical Cancer	MTT/MTS assay	56.81 Inhibition ratio at 50 µg/ml	24-h	Cervix	None
1678	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	HeLa	Cervical Cancer	MTT/MTS assay	52.32 Inhibition ratio at 50 µg/ml	24-h	Cervix	None
1677	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	SMMC-7721	Liver Cancer	MTT/MTS assay	86.175 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1676	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	SMMC-7721	Liver Cancer	MTT/MTS assay	70.39 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1675	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	SMMC-7721	Liver Cancer	MTT/MTS assay	59.37 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1674	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	SMMC-7721	Liver Cancer	MTT/MTS assay	52.77 Inhibition ratio at 50 µg/ml	24-h	Liver	None
1673	22641352	2012	RGDLLRHVVKILSKYL	RGD-Las	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	SW-1116	Colorectal Cancer	MTT/MTS assay	81.465 Inhibition ratio at 50 µg/ml	24-h	Colon	None
1672	22641352	2012	RGDLLRHVVKILEKYL	RGD-La	16	Linear	L	None	Free	Free	Anticancer	Arg-Gly-Asp(RGD) tripeptide ana temporins	SW-1116	Colorectal Cancer	MTT/MTS assay	72.69 Inhibition ratio at 50 µg/ml	24-h	Colon	None
1671	22641352	2012	LLRHVVKILSKYL	Temporin-Las	13	Linear	L	None	Free	Free	Anticancer	Temporins family	SW-1116	Colorectal Cancer	MTT/MTS assay	62.73 Inhibition ratio at 50 µg/ml	24-h	Colon	None
1670	22641352	2012	LLRHVVKILEKYL	Temporin-La	13	Linear	L	None	Free	Free	Anticancer	Temporins family	SW-1116	Colorectal Cancer	MTT/MTS assay	57.62 Inhibition ratio at 50 µg/ml	24-h	Colon	None
1546	22073006	2011	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin	33	Linear	L	None	Free	Free	Antibacterial	Red Sea Mosessole	HT-1080	Fibrosarcoma	MTT/MTS assay	IC₅₀=14.52 µg/ml	24-h	Fibrous connective tissue	None
1545	22073006	2011	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin	33	Linear	L	None	Free	Free	Antibacterial	Red Sea Mosessole	HT-1080	Fibrosarcoma	MTT/MTS assay	IC₅₀=14.51 µg/ml	12-h	Fibrous connective tissue	None
1544	22073006	2011	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin	33	Linear	L	None	Free	Free	Antibacterial	Red Sea Mosessole	HT-1080	Fibrosarcoma	MTT/MTS assay	IC₅₀=15.40 µg/ml	6-h	Not Available	None
1543	22073006	2011	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin	33	Linear	L	None	Free	Free	Antibacterial	Red Sea Mosessole	HT-1080	Fibrosarcoma	MTT/MTS assay	IC₅₀=15.74 µg/ml	3-h	Not Available	None
1524	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=2.2 µMo/L	36-h	Cervix	None
1523	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=2 µMo/L	36-h	Cervix	None
1522	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=4.3 µMo/L	36-h	Cervix	None
1521	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=3.8 µMo/L	36-h	Cervix	None
1520	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=10.4 µMo/L	36-h	Cervix	None
1519	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=58.6 µMo/L	36-h	Cervix	None
1518	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=64.7 µMo/L	36-h	Cervix	None
1517	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Cervix	None
1516	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Cervix	None
1515	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Cervix	None
1514	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=4.6 µMo/L	36-h	Skin	None
1513	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=4.4 µMo/L	36-h	Skin	None
1512	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=7.8 µMo/L	36-h	Skin	None
1511	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=5.2 µMo/L	36-h	Skin	None
1510	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=11.5 µMo/L	36-h	Skin	None
1509	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=62.5 µMo/L	36-h	Skin	None
1508	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=63.5 µMo/L	36-h	Skin	None
1507	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Skin	None
1506	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Skin	None
1505	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Skin	None
1504	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=2.7 µMo/L	36-h	Lung	None
1503	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=4.1 µMo/L	36-h	Lung	None
1502	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=2.9 µMo/L	36-h	Lung	None
1501	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=4.4 µMo/L	36-h	Lung	None
1500	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=4.7 µMo/L	36-h	Lung	None
1499	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=14 µMo/L	36-h	Lung	None
1498	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=15.6 µMo/L	36-h	Lung	None
1497	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=16.4 µMo/L	36-h	Lung	None
1496	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=37.7 µMo/L	36-h	Lung	None
1495	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Lung	None
1494	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=5.5 µMo/L	36-h	Muscle	None
1493	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=6.4 µMo/L	36-h	Muscle	None
1492	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=9.8 µMo/L	36-h	Muscle	None
1491	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=7.5 µMo/L	36-h	Muscle	None
1490	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=25.2 µMo/L	36-h	Muscle	None
1488	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Muscle	None
1489	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Muscle	None
1487	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Muscle	None
1486	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Muscle	None
1484	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=3.5 µMo/L	36-h	Colon	None
1485	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Muscle	None
1483	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=4.3 µMo/L	36-h	Colon	None
1482	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=5 µMo/L	36-h	Colon	None
1481	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=6.4 µMo/L	36-h	Colon	None
1480	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=11.1 µMo/L	36-h	Colon	None
1479	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Colon	None
1478	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Colon	None
1477	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Colon	None
1476	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Colon	None
1475	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Colon	None
1474	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=5.7 µMo/L	36-h	Breast	None
1473	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=6.2 µMo/L	36-h	Breast	None
1472	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=5.1 µMo/L	36-h	Breast	None
1471	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=5 µMo/L	36-h	Breast	None
1470	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=15.8 µMo/L	36-h	Breast	None
1469	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=62.3 µMo/L	36-h	Breast	None
1468	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=70.8 µMo/L	36-h	Breast	None
1467	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Breast	None
1466	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Breast	None
1465	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Breast	None
1464	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=7.2 µMo/L	36-h	Skin	None
1463	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=8.7 µMo/L	36-h	Skin	None
1462	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=6.5 µMo/L	36-h	Skin	None
1461	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=4.3 µMo/L	36-h	Skin	None
1460	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=17.8 µMo/L	36-h	Skin	None
1458	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=59.8 µMo/L	36-h	Skin	None
1459	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=58.7 µMo/L	36-h	Skin	None
1455	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Skin	None
1456	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Skin	None
1457	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Skin	None
1452	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=8.7 µMo/L	36-h	Lung	None
1453	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=9.7 µMo/L	36-h	Lung	None
1454	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=9.2 µMo/L	36-h	Lung	None
1449	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=53 µMo/L	36-h	Lung	None
1450	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=33 µMo/L	36-h	Lung	None
1451	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=11.1 µMo/L	36-h	Lung	None
1446	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Lung	None
1447	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Lung	None
1448	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=71 µMo/L	36-h	Lung	None
1445	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Lung	None
1438	21955251	2011	GIIKKIIIKKIIIKKIIIKKI	Cationic Amphiphilic	21	Cyclic	L	None	Free	Free	Antimicrobial	AMP	HL-60	Pancreatic Cancer	WST-1 assay	IC₅₀ = 10 µM	Not Available	Pancreatic	None
1437	21955251	2011	GIIKKIIIKKIIIKKI	Cationic Amphiphilic	16	Cyclic	L	None	Free	Free	Antimicrobial	AMP	HL-60	Pancreatic Cancer	WST-1 assay	IC₅₀ = 25 µM	Not Available	Pancreatic	None
1436	21955251	2011	GIIKKIIIKKI	Cationic Amphiphilic	11	Cyclic	L	None	Free	Free	Antimicrobial	AMP	HL-60	Pancreatic Cancer	WST-1 assay	IC₅₀ = >500 µM	Not Available	Pancreatic	None
1435	21955251	2011	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Free	Free	Antimicrobial	Xenopus laevis	HeLa	Pancreatic Cancer	WST-1 assay	IC₅₀ = >60 µM	Not Available	Pancreatic	None
1434	21955251	2011	GIIKKIIIKKIIIKKIIIKKI	Cationic Amphiphilic	21	Cyclic	L	None	Free	Free	Antimicrobial	AMP	HeLa	Pancreatic Cancer	WST-1 assay	IC₅₀ = 4 µM	Not Available	Pancreatic	None
1433	21955251	2011	GIIKKIIIKKIIIKKI	Cationic Amphiphilic	16	Cyclic	L	None	Free	Free	Antimicrobial	AMP	HeLa	Cervical Cancer	WST-1 assay	IC₅₀ = 15 µM	Not Available	Cervix	None
1432	21955251	2011	GIIKKIIIKKI	Cationic Amphiphilic	11	Cyclic	L	None	Free	Free	Antimicrobial	AMP	HeLa	Cervical Cancer	WST-1 assay	IC₅₀ = 160 µM	Not Available	Cervix	None